Page 11234

You are currently browsing the Quantum Medicine category

U of T and Hebrew University of Jerusalem launch research and innovation partnership – News@UofT

§ July 9th, 2020 § Filed under Quantum Medicine Comments Off on U of T and Hebrew University of Jerusalem launch research and innovation partnership – News@UofT

How did environmental conditions and climate change influence early human evolution? Can protein engineering be harnessed to block the virus that causes COVID-19? How do quantum mechanics affect biological functions, and how do our memory and learning work on a cellular level in the brain?

These are some of the big questions that will be explored by researchers at the University of Toronto and the Hebrew University of Jerusalem (HUJI) as part of a new strategic partnership that will allow faculty and students from the two institutions to combine resources to carry out high-impact research.

Each year, the University of Toronto Hebrew University of Jerusalem Research and Innovation Alliance will select projects to receive funding of $150,000 a year for up to four years, with each research group comprising faculty drawn from both universities and covering a range of disciplines. The alliance will also occasionally provide one-time seed funding to help get promising projects off the ground.

Initially launched with endowed funding of $5.9 million from the Canadian Friends of Hebrew University and the family of Roz and Ralph Halbert, the allianceaims to raise another $14 million and eventually construct an innovation pipeline between U of T and HUJI to connect the entrepreneurship ecosystems in Toronto and Jerusalem and provide student entrepreneurs with exposure to each others universities and markets.

[HUJIs] mandate with respect to research is very closely aligned to U of Ts in terms of leading the world in a variety of areas, and thats always the kind of partner were looking for, said Alex Mihailidis, U of Ts associate vice-president of international partnerships and a professor in the Faculty of Medicine's department of occupational science and occupational therapy, as well as the Institute of Biomaterials and Biomedical Engineering.

We both recognize that international collaborations strengthen the research within each university, and thats why were excited to partner with them.

He added that the timing of the partnership speaks to U of Ts commitment to forge ahead with research partnerships despite the challenges of working and collaborating amid the pandemic.

From an international partnerships perspective, its business as usual, said Mihailidis, who is also cross-appointed to the department of computer science in the Faculty of Arts & Science. Weve not shut anything down and weve not stopped collaborations. Were going full-speed ahead its looking a bit different, but we are still moving ahead both with existing and new partners.

Both researchersdeveloped an interest in the Kalahari Chazan as an archeologist analyzing early evidence of human activity and Matmon as a geologist carrying out dating techniques to study the evolution of the landscape and theyre now looking to combine their perspectives.

The next phase of work with this funding is to expand Aris geological work, particularly looking for evidence of wet environments, so we can try and understand when there was a shift to modern arid conditions, said Chazan. At the same time, Ill be working in the town of Kathu in South Africa, which is a major mining area today, and were looking at some very large sites and trying to understand what the conditions were when this place supported large groups of people.

So its a really new area of study that combines geological perspectives on how the landscape and hydrology evolved with an archeological perspective which is asking in more narrowly focused locations what the human behaviour was and what was drawing people to these sites.

Oron Shagrir, vice-president for international affairs at HUJI, said the partnership brings together the two leading universities in Israel and Canada, and that the call for research proposals resulted in several exciting submissions.

In these challenging and unprecedented times for societies and universities alike, international partnerships are an invaluable source of support and inspiration, said Shagrir, a professor of philosophy and cognitive science. They are not only an important asset and tool in advancing universities on all levels, but also serve as a valuable platform to promote and support collaborative research projects.

Chazan points to his project as an example of how the two universities can combine their respective strengths.

At U of T, were strong in terms of field archeology and geophysics, he said. Hebrew University is particularly strong in looking at the evolution of landforms over the period of the last two to five million years ... [and] that requires some very specialized labs.

Among the labs that Chazan and his students will have access to is a high-tech facility that blocks out any modern magnetic signals to precisely study fluctuations in the earths magnetic field. Having access to that is a major asset for the project and for our students, who get to learn how to operate in that kind of system, said Chazan.

Meanwhile, Sachdev Sidhu, a professor appointed to U of Ts Donnelly Centre for Cellular and Biomolecular Research, the department of molecular genetics and the Institute of Biomaterials and Biomedical Engineering, will be working with Professor Julia Shifman of HUJIs Alexander Silberman Institute of Life Science to study how the fast-growing fields of protein engineering and design can be leveraged to develop treatments for diseases, including COVID-19.

Their project will use insights gained from past outbreaks of coronaviruses to understand the functions of the proteins that power SARS-CoV-2 the virus that causes COVID-19 and to develop molecules with the potential to disarm the virus and pave the way to a potential cure.

Additionally, the U of T HUJI Research and Innovation Alliance is providing $5,000 in seed funding to two projects.

The first will see Professor Dvira Segal of U of Ts departments of chemistry and physics and Professor Roi Baer of HUJIs Fritz Haber Research Center for Molecular Dynamics and Institute of Chemistry explore the role of quantum processes in natural and engineered quantum systems.

The second aims to better understand how the brain acquires and stores information in order to help prevent and treat debilitating memory and learning disorders. The principal investigators are Associate Professors Sheena Josselyn and Paul Frankland of the department of physiology in U of Ts Faculty of Medicine, Professor Melanie Woodin of the department of cell and systems biology and HUJI scholars Adi Mizrahi, Ami Citri and Inbal Goshen.

Ronald Appleby, a U of T alumnus and campaign chair for the partnership, said the research efforts made possible by the partnership speak to the two universities shared commitment to advancing interdisciplinary teams of researchers and students working on translational research, bolstered by mutual respect and friendship.

The attention paid to research in engineering and medicine, the sciences, the social sciences, humanities, and law reflects our mutual interest in creating novel solutions for some of the most pressing current issues, Appleby said.

Originally posted here:

U of T and Hebrew University of Jerusalem launch research and innovation partnership - News@UofT

Read the Rest...

BREAKING: Earl Campbell, Gary Baxter’s Project Rose go to court with TSJH, Baylor, Scott and White over dueling claims of breach of contract – Tyler…

§ July 8th, 2020 § Filed under Quantum Medicine Comments Off on BREAKING: Earl Campbell, Gary Baxter’s Project Rose go to court with TSJH, Baylor, Scott and White over dueling claims of breach of contract – Tyler…

A lawsuit on behalf of the Tyler Rose and his partner NFL alum Gary Baxter alleges they haven't been paid "a red cent" for their work creating the Project Rose Research Institute for Sports Science.

TSJH's lawsuit claims Baxter and Earl Campbell did "little to actually build a sports science and medicine facility." The document alleges the institute hosted a few programs, put up a website, got some equipment and made occasional press statements about its "purported charitable endeavors."

An attorney for Campbell and Baxter said their organizations were fraudulently misled and used to promote and bolster the reputation of the hospital, but enjoyed no share of the profits when it was sold.

The counter lawsuit stated that "'When TSJH sucked everything it could from the relationship with the counter plaintiffs, and used Baxter and Campbell, to sell 50.25% of the hospital for in excess of $81,000,000, Tony Wahl told Mr. Baxter that "the hospital is giving notice to terminate the Project Rose license agreement as well as the consulting and lease agreement. Sometimes, despite everyone's best efforts, agreements like this do not work out,' and attempted to end the relationship without paying counter plaintiffs and Mr. Campbell and Mr. Baxter a red cent for all of their trade secrets, expertise, service and effort."

The Tyler Morning Telegraph has obtained court documents in which Texas Spine and Joint Hospital claims ProjectRose did not pay $200,000 in rent, and attempted to terminate the lease in August 2019. The hospital alleges that after paying the back rent, Project Rose attempted to invoice the hospital more than $4 million for 349 hours of consulting services per month dating from Aug. 2017 through Aug. 2019, which the hospital said are untrue, excessive and presented in contravention of their contractual obligations. The lawsuit states that these consulting invoices constituted a contract-violating demand.

When the hospital refused to pay Project Rose's demand, TSJH claims Baxter threatened to have a press conference announcing a lawsuit against TSJH but he never followed through.

The Project Rose Research Institute for Sports Science is a sports science institute located on the second floor of the Tyler hospital, unveiled in 2017 as a partnership between Campbell, Baxter and Texas Spine and Joint Hospital before the hospital sold a majority stake to Baylor, Scott and White. Three contracts were entered the first was a lease agreement between TSJH and Project Rose, the second a license agreement between PR Goal Line, owned by Baxter and Campbell, and TSJH and the third a consultant agreement between Project Rose and TSJH, at an hourly rate of $500.

The goal of the facility was to provide sports medicine research to create safer playing environments for athletes from grade school to professional sports.

That lawsuit was filed by the hospital on Feb. 24. A counter suit was filed on behalf of Project Rose and Touchdown Interception on April 17, adding Baylor, Scott and White as third party defendants. Baylor Scott and White Health is handling its filings separately from TSJH.

The counter suit states Project Rose MSO was persuaded to make a verbal agreement to postpone invoices and TSJH would postpone the rental obligations, at the request of TSJH CEO Tony Wahl. The document states that upon notification of the alleged unpaid rent, Project Rose paid the full $197,000 within 30 days and remains current on its rental obligations, even though TSJH removed their signage from the facility.

Parties named as defendants by TSJH include Project Rose, 62 Roses MSO and Touchdown Interception, LLC, which are run by Baxter and Campbell.

In the counter-claim, Project Rose's attorney Wade McClure states that Campbell and Baxter passed on other offers to partner with other hospitals, and leveraged their sports experience, trade secrets, intellectual property and time and effort to create a state of the art athlete focused sports medicine facility, but TSJH attempted to continually change the terms of their agreement, without paying Campbell and Baxter "a red cent." McClure and co-counsel Jennifer Ainsworth, of the Tyler based Wilson Robertson & Cornelius firm, represent the various companies headed by Baxter and Campbell.

The countersuit states that under the agreement with TSJH, Touchdown Interception was entitled to 50% of the profits from the facility after TSJH recouped its capital contribution up to the amount of $1.3 million.

McClure states that his clients repeatedly tried to ascertain whether the facility was profitable and were not given a full disclosure.

McClure said they have requested a full accounting of the facility to determine its profits and what his clients are owed. He said the legal actions include a cause for consulting fees for Project Rose MSO and a separate cause for the profit sharing agreement for the sports clinic.

Wesley Hill, one of Texas Spine and Joint Hospital's attorneys, supported the claims made in the original lawsuit filing.

"We dispute Project Rose's claims and our position is made clear in the lawsuit, which is why we brought it to the court," Hill said.

The countersuit states that TSJH used the product and concept of Project Rose in competition without paying for the product and concepts, allowing the hospital to benefit from a special advantage.

"We are just seeking to receive compensation for the substantial work, services and commitment to the facility," McClure said. "And basically the hospital has chosen not to pay anything for all the services, all the efforts, all the good will my clients have put in to building the facility."

The countersuit accuses Baylor, Scott and White of theft of trade secrets and intellectual property, fraudulent inducement and fraud, tortious interference with existing contract, unfair competition, common law misappropriation, promissory estoppel and detrimental reliance, quantum meruit (a legal term for recovering value of services), unjust enrichment, civil conspiracy, aiding and abetting and knowingly participating in TSJH's breaches of fiduciary duties and other wrongful conduct.

On June 26, the Baylor Scott and White Hospital system filed a motion to dismiss under the Texas anti-SLAAP statute, denying all claims. McClure said the motion has effectively put the lawsuit in a stay until that is resolved, which can take up to 120 days. Anti-SLAPP, or anti-Strategic Lawsuit Against Public Participation, laws are designed to provide for early dismissal of meritless lawsuits filed against people for the exercise of First Amendment rights, according to medialaw.org.

The Tyler Paper has reached out to the hospital system's attorney for comment.

This story will be updated.

Continued here:

BREAKING: Earl Campbell, Gary Baxter's Project Rose go to court with TSJH, Baylor, Scott and White over dueling claims of breach of contract - Tyler...

Read the Rest...

Complementary and Alternative Medicine Market 2020:Key market Insights, Drivers and Restraints, Opportunities and Challenges, Sales and Revenue and…

§ July 8th, 2020 § Filed under Quantum Medicine Comments Off on Complementary and Alternative Medicine Market 2020:Key market Insights, Drivers and Restraints, Opportunities and Challenges, Sales and Revenue and…

Complementary and Alternative Medicine Market Research Report

Los Angeles, United States, July 8th, 2020, The report on the global Complementary and Alternative Medicine market is comprehensively prepared with main focus on the competitive landscape, geographical growth, segmentation, and market dynamics, including drivers, restraints, and opportunities. It sheds light on key production, revenue, and consumption trends so that players could improve their sales and growth in the Global Complementary and Alternative Medicine Market. It offers a detailed analysis of the competition and leading companies of the global Complementary and Alternative Medicine market. Here, it concentrates on the recent developments, sales, market value, production, gross margin, and other important factors of the business of top players operating in the global Complementary and Alternative Medicine market.

With deep quantitative and qualitative analysis, the report provides encyclopedic and accurate research study on important aspects of the global Complementary and Alternative Medicine market. It brings to light key factors affecting the growth of different segments and regions in the global Complementary and Alternative Medicine market. It also offers SWOT, Porters Five Forces, and PESTLE analysis to thoroughly examine the global Complementary and Alternative Medicine market. It gives a detailed study on manufacturing cost, upstream and downstream buyers, distributors, marketing strategy, and marketing channel development trends of the global Complementary and Alternative Medicine market. Furthermore, it provides strategic bits of advice and recommendations for players to ensure success in the global Complementary and Alternative Medicine market.

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1698359/covid-19-impact-on-global-complementary-and-alternative-medicine-market

Some of the Important Key player operating in this Report are: , Columbia Nutritional, Herb Pharm, Herbal Hills, Helio USA, Deepure Plus, Nordic Naturals, Pure encapsulations, Iyengar Yoga Institute, John Schumachers Unity Woods Yoga Center, Yoga Tree, The Healing Company, Quantum Touch Complementary and Alternative Medicine

Segmental Analysis

The report has classified the global Complementary and Alternative Medicine industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Complementary and Alternative Medicine manufacturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Railway Signaling System industry.

Complementary and Alternative Medicine Segmentation by Product

, Botanicals, Acupuncture, Mind, Body, and Yoga, Magnetic Intervention Complementary and Alternative Medicine

Complementary and Alternative Medicine Segmentation by Application

Direct Contact, E-training, Distance Correspondence

Regions and Countries

The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Key Questions Answered

What is the size and CAGR of the global Complementary and Alternative Medicine market?

Which are the leading segments of the global Complementary and Alternative Medicine market?

What are the key driving factors of the most profitable regional market?

What is the nature of competition in the global Complementary and Alternative Medicine market?

How will the global Complementary and Alternative Medicine market advance in the coming years?

What are the main strategies adopted in the global Complementary and Alternative Medicine market?

Enquiry for Customization in the Report @https://www.qyresearch.com/customize-request/form/1698359/covid-19-impact-on-global-complementary-and-alternative-medicine-market

Table of Contents

1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Complementary and Alternative Medicine Revenue 1.4 Market Analysis by Type 1.4.1 Global Complementary and Alternative Medicine Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Botanicals 1.4.3 Acupuncture 1.4.4 Mind, Body, and Yoga 1.4.5 Magnetic Intervention 1.5 Market by Application 1.5.1 Global Complementary and Alternative Medicine Market Share by Application: 2020 VS 2026 1.5.2 Direct Contact 1.5.3 E-training 1.5.4 Distance Correspondence 1.6 Coronavirus Disease 2019 (Covid-19): Complementary and Alternative Medicine Industry Impact 1.6.1 How the Covid-19 is Affecting the Complementary and Alternative Medicine Industry

1.6.1.1 Complementary and Alternative Medicine Business Impact Assessment Covid-19

1.6.1.2 Supply Chain Challenges

1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Complementary and Alternative Medicine Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19

1.6.3.1 Government Measures to Combat Covid-19 Impact

1.6.3.2 Proposal for Complementary and Alternative Medicine Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Complementary and Alternative Medicine Market Perspective (2015-2026) 2.2 Complementary and Alternative Medicine Growth Trends by Regions 2.2.1 Complementary and Alternative Medicine Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Complementary and Alternative Medicine Historic Market Share by Regions (2015-2020) 2.2.3 Complementary and Alternative Medicine Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porters Five Forces Analysis 2.3.5 Complementary and Alternative Medicine Market Growth Strategy 2.3.6 Primary Interviews with Key Complementary and Alternative Medicine Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Complementary and Alternative Medicine Players by Market Size 3.1.1 Global Top Complementary and Alternative Medicine Players by Revenue (2015-2020) 3.1.2 Global Complementary and Alternative Medicine Revenue Market Share by Players (2015-2020) 3.1.3 Global Complementary and Alternative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Complementary and Alternative Medicine Market Concentration Ratio 3.2.1 Global Complementary and Alternative Medicine Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Complementary and Alternative Medicine Revenue in 2019 3.3 Complementary and Alternative Medicine Key Players Head office and Area Served 3.4 Key Players Complementary and Alternative Medicine Product Solution and Service 3.5 Date of Enter into Complementary and Alternative Medicine Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Complementary and Alternative Medicine Historic Market Size by Type (2015-2020) 4.2 Global Complementary and Alternative Medicine Forecasted Market Size by Type (2021-2026) 5 Complementary and Alternative Medicine Breakdown Data by Application (2015-2026) 5.1 Global Complementary and Alternative Medicine Market Size by Application (2015-2020) 5.2 Global Complementary and Alternative Medicine Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Complementary and Alternative Medicine Market Size (2015-2020) 6.2 Complementary and Alternative Medicine Key Players in North America (2019-2020) 6.3 North America Complementary and Alternative Medicine Market Size by Type (2015-2020) 6.4 North America Complementary and Alternative Medicine Market Size by Application (2015-2020) 7 Europe 7.1 Europe Complementary and Alternative Medicine Market Size (2015-2020) 7.2 Complementary and Alternative Medicine Key Players in Europe (2019-2020) 7.3 Europe Complementary and Alternative Medicine Market Size by Type (2015-2020) 7.4 Europe Complementary and Alternative Medicine Market Size by Application (2015-2020) 8 China 8.1 China Complementary and Alternative Medicine Market Size (2015-2020) 8.2 Complementary and Alternative Medicine Key Players in China (2019-2020) 8.3 China Complementary and Alternative Medicine Market Size by Type (2015-2020) 8.4 China Complementary and Alternative Medicine Market Size by Application (2015-2020) 9 Japan 9.1 Japan Complementary and Alternative Medicine Market Size (2015-2020) 9.2 Complementary and Alternative Medicine Key Players in Japan (2019-2020) 9.3 Japan Complementary and Alternative Medicine Market Size by Type (2015-2020) 9.4 Japan Complementary and Alternative Medicine Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Complementary and Alternative Medicine Market Size (2015-2020) 10.2 Complementary and Alternative Medicine Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Complementary and Alternative Medicine Market Size by Type (2015-2020) 10.4 Southeast Asia Complementary and Alternative Medicine Market Size by Application (2015-2020) 11 India 11.1 India Complementary and Alternative Medicine Market Size (2015-2020) 11.2 Complementary and Alternative Medicine Key Players in India (2019-2020) 11.3 India Complementary and Alternative Medicine Market Size by Type (2015-2020) 11.4 India Complementary and Alternative Medicine Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Complementary and Alternative Medicine Market Size (2015-2020) 12.2 Complementary and Alternative Medicine Key Players in Central & South America (2019-2020) 12.3 Central & South America Complementary and Alternative Medicine Market Size by Type (2015-2020) 12.4 Central & South America Complementary and Alternative Medicine Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Columbia Nutritional 13.1.1 Columbia Nutritional Company Details 13.1.2 Columbia Nutritional Business Overview and Its Total Revenue 13.1.3 Columbia Nutritional Complementary and Alternative Medicine Introduction 13.1.4 Columbia Nutritional Revenue in Complementary and Alternative Medicine Business (2015-2020)) 13.1.5 Columbia Nutritional Recent Development 13.2 Herb Pharm 13.2.1 Herb Pharm Company Details 13.2.2 Herb Pharm Business Overview and Its Total Revenue 13.2.3 Herb Pharm Complementary and Alternative Medicine Introduction 13.2.4 Herb Pharm Revenue in Complementary and Alternative Medicine Business (2015-2020) 13.2.5 Herb Pharm Recent Development 13.3 Herbal Hills 13.3.1 Herbal Hills Company Details 13.3.2 Herbal Hills Business Overview and Its Total Revenue 13.3.3 Herbal Hills Complementary and Alternative Medicine Introduction 13.3.4 Herbal Hills Revenue in Complementary and Alternative Medicine Business (2015-2020) 13.3.5 Herbal Hills Recent Development 13.4 Helio USA 13.4.1 Helio USA Company Details 13.4.2 Helio USA Business Overview and Its Total Revenue 13.4.3 Helio USA Complementary and Alternative Medicine Introduction 13.4.4 Helio USA Revenue in Complementary and Alternative Medicine Business (2015-2020) 13.4.5 Helio USA Recent Development 13.5 Deepure Plus 13.5.1 Deepure Plus Company Details 13.5.2 Deepure Plus Business Overview and Its Total Revenue 13.5.3 Deepure Plus Complementary and Alternative Medicine Introduction 13.5.4 Deepure Plus Revenue in Complementary and Alternative Medicine Business (2015-2020) 13.5.5 Deepure Plus Recent Development 13.6 Nordic Naturals 13.6.1 Nordic Naturals Company Details 13.6.2 Nordic Naturals Business Overview and Its Total Revenue 13.6.3 Nordic Naturals Complementary and Alternative Medicine Introduction 13.6.4 Nordic Naturals Revenue in Complementary and Alternative Medicine Business (2015-2020) 13.6.5 Nordic Naturals Recent Development 13.7 Pure encapsulations 13.7.1 Pure encapsulations Company Details 13.7.2 Pure encapsulations Business Overview and Its Total Revenue 13.7.3 Pure encapsulations Complementary and Alternative Medicine Introduction 13.7.4 Pure encapsulations Revenue in Complementary and Alternative Medicine Business (2015-2020) 13.7.5 Pure encapsulations Recent Development 13.8 Iyengar Yoga Institute 13.8.1 Iyengar Yoga Institute Company Details 13.8.2 Iyengar Yoga Institute Business Overview and Its Total Revenue 13.8.3 Iyengar Yoga Institute Complementary and Alternative Medicine Introduction 13.8.4 Iyengar Yoga Institute Revenue in Complementary and Alternative Medicine Business (2015-2020) 13.8.5 Iyengar Yoga Institute Recent Development 13.9 John Schumachers Unity Woods Yoga Center 13.9.1 John Schumachers Unity Woods Yoga Center Company Details 13.9.2 John Schumachers Unity Woods Yoga Center Business Overview and Its Total Revenue 13.9.3 John Schumachers Unity Woods Yoga Center Complementary and Alternative Medicine Introduction 13.9.4 John Schumachers Unity Woods Yoga Center Revenue in Complementary and Alternative Medicine Business (2015-2020) 13.9.5 John Schumachers Unity Woods Yoga Center Recent Development 13.10 Yoga Tree 13.10.1 Yoga Tree Company Details 13.10.2 Yoga Tree Business Overview and Its Total Revenue 13.10.3 Yoga Tree Complementary and Alternative Medicine Introduction 13.10.4 Yoga Tree Revenue in Complementary and Alternative Medicine Business (2015-2020) 13.10.5 Yoga Tree Recent Development 13.11 The Healing Company 10.11.1 The Healing Company Company Details 10.11.2 The Healing Company Business Overview and Its Total Revenue 10.11.3 The Healing Company Complementary and Alternative Medicine Introduction 10.11.4 The Healing Company Revenue in Complementary and Alternative Medicine Business (2015-2020) 10.11.5 The Healing Company Recent Development 13.12 Quantum Touch 10.12.1 Quantum Touch Company Details 10.12.2 Quantum Touch Business Overview and Its Total Revenue 10.12.3 Quantum Touch Complementary and Alternative Medicine Introduction 10.12.4 Quantum Touch Revenue in Complementary and Alternative Medicine Business (2015-2020) 10.12.5 Quantum Touch Recent Development 14 Analysts Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.

See the article here:

Complementary and Alternative Medicine Market 2020:Key market Insights, Drivers and Restraints, Opportunities and Challenges, Sales and Revenue and...

Read the Rest...

Leading Public Health Experts to Oversee Development of Enhanced Cruise Line Health and Safety Standards – PR Newswire UK

§ July 6th, 2020 § Filed under Quantum Medicine Comments Off on Leading Public Health Experts to Oversee Development of Enhanced Cruise Line Health and Safety Standards – PR Newswire UK

"Healthy Sail Panel" comprises top experts in public health, infectious disease, biosecurity, hospitality and maritime operations

MIAMI, July 6, 2020 /PRNewswire/ -- Cruise industry leaders Royal Caribbean Group (NYSE: RCL) and Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) announced a collaboration to develop enhanced cruise health and safety standards in response to the global COVID-19 pandemic. The companies have asked Governor Mike Leavitt and Dr. Scott Gottlieb to serve as co-chairs of a newly formed group of experts called the "Healthy Sail Panel." The panel is tasked with collaboratively developing recommendations for cruise lines to advance their public health response to COVID-19, improve safety, and achieve readiness for the safe resumption of operations.

The expert panel has been working for nearly a month and will offer its initial recommendations by the end of August.The cruise lines said its work will be "open source," and could be freely adopted by any company or industry that would benefit from the group's scientific and medical insights.

"This unprecedented disease requires us to develop unprecedented standards in health and safety," said Richard D. Fain, chairman and CEO of Royal Caribbean Group. "Bringing aboard these respected experts to guide us forward demonstrates our commitment to protecting our guests, our crews and the communities we visit."

"We compete for the vacationing consumer's business every day, but we never compete on health and safety standards," said Frank Del Rio, president and CEO of Norwegian Cruise Line Holdings Ltd. "While the cruise industry has always had rigorous health standards, the unique challenges posed by COVID-19 provide an opportunity to raise the bar even higher."

"Health and safety are the highest priority for all CLIA cruise line members as demonstrated by this initiative on the part of two of our largest members. We commend this and parallel efforts of all of our members, large and small, who are working tirelessly to develop appropriate protocols based on input from health authorities and medical experts in the U.S. and abroad," said Kelly Craighead, president and CEO of Cruise Lines International Association (CLIA).

Fain and Del Rio said they initiated the panel to assure the plans they will submit to the U.S. Centers for Disease Control and Prevention (CDC) and other regulators apply the best available public health, science and engineering insights. The work of the panel will be shared with the entire industry and regulators.

"In convening the Healthy Sail Panel, we sought the participation of a diverse group of leading experts in areas of science and public health that are directly relevant to the considerations listed by the No Sail Order," said Governor Leavitt. "We view our work as a profoundly important public health effort. The health and safety of passengers, crew, and the communities that cruise ships visit will be the principal focus of this project."

Dr. Gottlieb said, "We know that the public health issues that must be addressed are complex, and in some areas, tackling them will require novel approaches. Our goal in assembling this team of leading experts was to develop best practices that can improve safety and provide a roadmap for reducing the risks of COVID-19."

The panel is co-chaired by Governor Leavitt, former Secretary of the U.S. Department Health and Human Services (HHS), and Dr. Scott Gottlieb, former commissioner of the U.S. Food and Drug Administration (FDA). The panel's members are globally recognized experts from various disciplines, including public health, infectious disease, biosecurity, hospitality and maritime operations.

The members of the expert panel are:

Governor Mike Leavitt Mike Leavitt was a three term Governor of Utah and served as Administrator of the EPA and Secretary of HHS under President George W. Bush. He is the founder of Leavitt Partners, a firm that provides investment support, data and analytics, member-based alliances, and direct services to clients to support decision-making strategies in the value economy.

Dr. Scott Gottlieb Dr. Scott Gottlieb was the Commissioner of the FDA from 2017-2019 and served as the agency's Deputy Commissioner for Medical and Scientific Affairs from 2005-2007. He is a physician trained in internal medicine and is currently a resident fellow at the American Enterprise Institute.

Helene Gayle M.D., MPH Dr. Gayle is CEO of the Chicago Community Trust, one of the nation's leading community foundations. Prior to this role, foralmost a decade, she was president and CEO of CARE, a leading international humanitarian organization. An expert on global development, humanitarian and health issues, Dr. Gayle spent 20 years with the CDC, working primarily on HIV/AIDS. She worked at the Bill & Melinda Gates Foundation, directing programs on HIV/AIDS and other global health issues. She also launched the McKinsey Social Initiative (now McKinsey.org), a nonprofit that builds partnerships for social impact. Dr. Gayle serves on public company and nonprofit boards, including The Coca-Cola Company, Colgate-Palmolive Company, the Brookings Institution, the Center for Strategic and International Studies, New America, the ONE Campaign, the Federal Reserve Bank of Chicago and the Economic Club of Chicago. She is a member of the Council on Foreign Relations, the American Public Health Association, the National Academy of Medicine, the National Medical Association and the American Academy of Pediatrics.

Julie Gerberding, M.D., MPH Dr. Julie L. Gerberding is Executive Vice President and Chief Patient Officer for Merck, leading all aspects of strategic communications, global public policy, population health and patient engagement.

A former head of the CDC and a world-renowned public health expert, Dr. Gerberding is deeply committed to achieving sustainable global health impact and tackling some of the most challenging health priorities of our time. This includes addressing critical issues such as affordable access to important therapies, advocating for health policies that promote and sustain innovation of new medicines and vaccines, and improving maternal mortality through the Merck for Mothers program a public-private partnership helping to meet the United Nations' Sustainable Development Goal to reduce maternal mortality.

Prior to joining Merck, Dr. Gerberding served as the Director of the CDC from 2002-2009 and was the first female to hold that position. While at the agency, she led more than 40 emergency responses against crises such as anthrax, SARS, bird flu, food-borne outbreaks and natural disasters. Previously, Dr. Gerberding was a tenured faculty member in Infectious Diseases at the University of California at San Francisco (UCSF). She continues as an Adjunct Associate Clinical Professor of Medicine at UCSF.

Steven Hinrichs, M.D. Dr. Steven Hinrichs is Professor and Chair in the Department of Pathology and Microbiology at the University of Nebraska Medical Center in Omaha and the Director of the Nebraska Public Health Laboratory (NPHL), and Director of the University of Nebraska Center for Biosecurity. In his position as laboratory director he has been responsible for the development of a statewide program for the rapid identification of biological agents of mass destruction. He is principal investigator of multiple national awards from the Association of Public Health Laboratories (APHL) and the CDC and the U.S. Department of Defense for the development of an outreach program to extend training and expertise in the early recognition of biological warfare agents. Dr. Hinrichs received his M.D. from the University of North Dakota and is board certified in Anatomical and Clinical Pathology. His research laboratory focuses on molecular diagnostics and the role of viruses in cancer. Dr. Hinrichs has published over 130 papers in basic science and medical journals.

Michael Osterholm, M.D., Ph.DMichael Osterholm is one of the nation's foremost experts in public health, infectious disease and biosecurity. As the director of the Center for Infectious Disease Research and Policy at the University of Minnesota, he is an international leader on the world's preparedness for pandemics. He has led numerous investigations into internationally important disease outbreaks, including foodborne diseases, hepatitis B in health care settings, and HIV infection in healthcare workers, and he is a frequent consultant to the World Health Organization, the National Institutes of Health, the FDA, the U.S. Department of Defense and the CDC. From 2001 to 2005, Dr. Osterholm served as a special advisor to the Secretary of HHS on issues related to bioterrorism and public health preparedness. From June 2018 through May 2019, he served as a Science Envoy for Health Security on behalf of the U.S. Department of State. He has also been appointed to the National Science Advisory Board on Biosecurity and the World Economic Forum's Working Group on Pandemics, among other prominent advisory positions.

Stephen Ostroff, M.D.Dr. Ostroff brings years of experience in public health, having served at high level positions at the FDA and CDC. He was the Acting Commissioner of the FDA from 2015-2016, and before that served as the FDA's chief scientist. Ostroff joined the FDA in 2013 as chief medical officer in the Center for Food Safety and Applied Nutrition and senior public health advisor to FDA's Office of Foods and Veterinary Medicine. Prior to that he served as deputy director of the National Center for Infectious Diseases at the CDC, where he was also acting director of CDC's Select Agent Program. While at the CDC he focused on emerging infectious diseases, food safety, and coordination of complex outbreak response. He retired from the Commissioned Corps of the U.S. Public Health Service at the rank of Rear Admiral (Assistant Surgeon General). Ostroff was also the director of the Bureau of Epidemiology and acting physician general for the Commonwealth of Pennsylvania and has consulted internationally on public health projects in South Asia and Latin America. Ostroff graduated from the University of Pennsylvania School of Medicine in 1981 and completed residencies in internal medicine at the University of Colorado Health Sciences Center and preventive medicine at CDC.

William Rutala, Ph.D, M.S., MPH Dr. Rutala has experience medically managing a variety of diseases and extensive experience studying epidemiology and virology, particularly managing outbreaks and emerging pathogens.Dr. Rutala's research interests are the etiology and prevention of healthcare-associated infections with a special focus on disinfection and sterilization of reusable medical and surgical devices (e.g., endoscopes, surgical instruments). Other areas of active research include contribution of the hospital environment to disease transmission, hand hygiene, preventing transmission of infectious agents, including multiply-drug resistant organisms, prevention of healthcare-associated Creutzfeldt-Jakob Disease, investigation of healthcare-associated outbreaks, and new and emerging pathogens in healthcare.

Kate Walsh, Ph.DKate Walsh is the Dean at the School of Hotel Administration at Cornell University and E.M. Statler Professor. A professor of management, she is a leader in education for the global hospitality industry; and a renowned expert in organizational service design, leadership and career development, as well as the impact of strategic human capital investments. In addition to authoring and contributing to books, Dr. Walsh's articles have appeared in numerous research outlets. She has over 20 years of academic experience, including in her current role as dean.

In addition, Dean Walsh holds extensive industry knowledge from serving as the former director of training and development for Nikko Hotels International, corporate training manager for the former Bristol Hotels, and senior auditor for Loews Corporation. She is also a former New York State Certified Public Accountant. Since the beginning of her administration as dean, Dean Walsh has focused on positioning the school for the future of education. This includes undertaking a comprehensive renewal of the graduate and undergraduate curricula, developing the school's online global presence, identifying international partners for master-level program development, and providing thought leadership for the hospitality industry, most notably through the creation of industry research partnerships for faculty, fostering new initiatives through the school's six centers and institutes, and providing faculty-developed resources to guide the industry. Dr. Walsh received her Ph.D. from the Carroll School of Management at Boston College and her M.P.S. degree from Cornell's School of Hotel Administration.

Captain Patrik DahlgrenCaptain Patrik Dahlgren is the Senior Vice President of Global Marine Operations and Fleet Optimization for all Royal Caribbean Groupglobal brands. Dahlgren's seagoing experiences started as a bridge officer aboard tugboats, yachts and an array of cargo vessels and ferries. He rose through the ranks with over 15 years onboard Royal Caribbean International cruise ships, with his last seagoing command as Master of Oasis of the Seas and Quantum of the Seas. He was a lead contributor to the Quantum of the Seas development and received the esteemed RINA (Royal Institute of Naval Architects) award for its innovation and contributions to maritime safety.

Robin LindsayRobin Lindsay is the Executive Vice President of Vessel Operations for Norwegian Cruise Line Holdings Ltd. Lindsay was appointed to this position in January 2015. In this role, Lindsay is responsible for Marine & Technical Operations, Hotel Operations, Entertainment, Product Development, Port & Destination Services, Fleet Personnel, Out Islands and New Build & Ship Refurbishment for all three of the company's brands Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises.

Prior to joining Norwegian Cruise Line Holdings Ltd., Lindsay served in a similar capacity as Executive Vice President of Vessel Operations at Prestige Cruise Holdings, the parent company of Oceania Cruises and Regent Seven Seas Cruises. Lindsay's history with the company goes back to the inception of Oceania Cruises in 2003, where he joined as Senior Vice President, Hotel Operations and Vessel Operations. Lindsay earned his B.S. degree from Louisiana Tech University.

In addition, several experts will also serve as senior advisors to the panel, including Dr. Caitlin Rivers, who is a faculty member and epidemiologist at the Johns Hopkins Bloomberg School of Public Health and an expert in emerging infectious disease epidemiology and outbreak science, and Dr. Phyllis Kozarsky, who is a professor emerita of medicine in the Division of Infectious Diseases at Emory University School of Medicine and an expert in pre-travel health advice and education, global health, and the epidemiology of travel related infections and infectious diseases. Dr. Kozarsky serves as an expert consultant to the Division of Global Migration and Quarantine in travelers' health with the CDC.

More assets available here:

About Royal Caribbean GroupRoyal Caribbean Group (NYSE: RCL) is a global cruise vacation company that controls and operates four global brands: Royal Caribbean International, Celebrity Cruises, Azamara and Silversea Cruises. The Company is also a 50% joint venture owner of the German brand TUI Cruises and a 49% shareholder of the Spanish brand Pullmantur. Together these brands operate a combined total of 62 ships with an additional 16 on order as of March 31, 2020. They operate diverse itineraries around the world that call on all seven continents. Additional information can be found on http://www.royalcaribbean.com, http://www.celebritycruises.com, http://www.azamara.com, http://www.silversea.com, http://www.tuicruises.com, http://www.pullmantur.es, http://www.rclcorporate or http://www.rclinvestor.com.

About Norwegian Cruise Line Holdings Ltd.Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) is a leading global cruise company which operates the Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises brands. With a combined fleet of 28 ships with approximately 59,150 berths, these brands offer itineraries to more than 490 destinations worldwide. The Company will introduce nine additional ships through 2027.

Cautionary Statement Concerning Forward-Looking StatementsSome of the statements contained in this release are "forward-looking statements" within the meaning of the U.S. federal securities laws intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this release, including, without limitation, those regarding business strategies, plans, and objectives for future operations (including those regarding efforts made by the panel and future health and safety protocols) are forward-looking statements. Many, but not all, of these statements can be found by looking for words like "expect," "plan," "will," "may," and similar words. Forward-looking statements do not guarantee future performance and may involve risks, uncertainties and other factors which could cause actual results, performance or achievements to differ materially from the future results, performance or achievements expressed or implied in those forward-looking statements. Examples of these risks, uncertainties and other factors include, but are not limited to the impact of: the spread of epidemics, pandemics and viral outbreaks and specifically, the COVID-19 outbreak, including its effect on the ability or desire of people to travel (including on cruises); the ability to develop strategies to enhance health and safety protocols to adapt to the current pandemic environment's unique challenges once operations resume and to otherwise safely resume operations when conditions allow; coordination and cooperation with the CDC, the federal government and global public health authorities to take precautions to protect the health, safety and security of guests, crew and the communities visited and the implementation of any such precautions; and other factors set forth under "Risk Factors" in each respective company's most recently filed Annual Report on Form 10-K, Quarterly Report on Form 10-Q and subsequent filings with the Securities and Exchange Commission. It is not possible to predict or identify all such risks. There may be additional risks that are considered immaterial or which are unknown. The above examples are not exhaustive and new risks emerge from time to time. Such forward-looking statements are based on current beliefs, assumptions, expectations, estimates and projections regarding present and future business strategies and the environment in which we expect to operate in the future. These forward-looking statements speak only as of the date made. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement to reflect any change in our expectations with regard thereto or any change of events, conditions or circumstances on which any such statement was based.

Photo - https://mma.prnewswire.com/media/1200307/1Governor_Mike_Leavitt.jpg Photo - https://mma.prnewswire.com/media/1200308/2Scott_Gottlieb.jpg Photo - https://mma.prnewswire.com/media/1200309/3Helene_Gayle.jpg Photo - https://mma.prnewswire.com/media/1200310/4Julie_Gerberding.jpg Photo - https://mma.prnewswire.com/media/1200311/5Steven_Hinirichs.jpg Photo - https://mma.prnewswire.com/media/1200312/6Micheal_Osterholm.jpg Photo - https://mma.prnewswire.com/media/1200313/7Stephan_Ostroff.jpg Photo - https://mma.prnewswire.com/media/1200314/8William_Rutala.jpg Photo - https://mma.prnewswire.com/media/1200315/9Kate_Walsh.jpg Photo - https://mma.prnewswire.com/media/1200316/10Patrick_Dahlgren.jpg Photo - https://mma.prnewswire.com/media/1200317/11Robin_Lindsay.jpg Logo - https://mma.prnewswire.com/media/1200435/Royal_and_Norwegian_Logo.jpg

https://www.nclhltdinvestor.com/

SOURCE Royal Caribbean Group & Norwegian Cruise Line Holdings Ltd.

See the article here:

Leading Public Health Experts to Oversee Development of Enhanced Cruise Line Health and Safety Standards - PR Newswire UK

Read the Rest...

OPINION | 100 days of lockdown: Success stories need to bring some balance to Covid-19 narrative – News24

§ July 6th, 2020 § Filed under Quantum Medicine Comments Off on OPINION | 100 days of lockdown: Success stories need to bring some balance to Covid-19 narrative – News24

Health workers may be experiencing challenges as they fight Covid-19, but there are also positive developments happening in the field that need to be celebrated, writesMarc Mendelson.

The pandemic of novel coronavirus, SARS-CoV-2, which causes Covid-19, has now claimed over half a million lives and close to 11 million confirmed infections worldwide.1 At home, the seriousness of the situation has required a state of national disaster to be declared, with all the health, social, and economic consequences that it brings.

Lifting of the lockdown brings with it its own challenges for how we, as a society, embrace the new norm of how we live our daily lives and prevent the transmission of the virus to our family, friends and within our communities and at work. There is no getting away from the seriousness of the situation, nor can any broadening of the narrative belittle its gravity.

However, it is time that a modicum of balance is brought to the sense of helplessness and nihilism that is becoming entrenched in society. There are success stories out there, that need to be heard.

Scientific tools

We have remarkable scientific tools at our disposal, that have allowed us to isolate, diagnose, monitor and treat the virus, at a pace not seen with even modern epidemics of Ebola, HIV or previous coronaviruses.

From the start of this epidemic, we were faced with a rapidly evolving field. The last decade has seen quantum leaps in scientific advances that we are now benefitting from, especially in the field of emerging and re-emerging infectious diseases; the identification of SARS-CoV-2 only days after the announcement of atypical pneumonia cases in Wuhan occurred at unprecedented speed, closely followed by a diagnostic test for the virus that allowed outbreak investigations and accelerated understanding of the rapidly expanding global pandemic.

South African expertise in outbreak control, including listeria and drug resistant TB, along with public health expertise in HIV, have allowed for rapid in-depth analysis in a way that rivals many European countries and certainly the US.

In addition, new ways in which we perform clinical trials with "adaptive" designs means that medicines that may be of benefit in treating an emerging infection can be studied rapidly, and a "go-no go" given much earlier than previously possible.

Again, South Africa's rich research community, largely having cut its teeth on infectious diseases and vaccine research during the last 20 years, has swiftly pivoted and begun evaluating a large number of prevention and treatment options. In South Africa, and across the globe, our management of this pandemic has been greatly improved by these advances.

In just a few months, we have acquired enough knowledge to return most people to health, with increasing success in people with severe disease. The pandemic has transfixed society on macro-level numbers, chief among which are the number of cases and the number of deaths. Little attention is given to the number of persons who have recovered.

While about half of the people infected by SARS-CoV-2 will have no symptoms at all (asymptomatic), most of those that do develop symptoms (~80%) will have mild disease, which can be managed at home.

What about outcomes of those that have the most severe disease and require admission to hospital? The most recent DATCOV report from the National Institute for Communicable Diseases (NICD 28th June 2020) tells of 14 555 people admitted to 278 public and private hospitals, countrywide.2

Advances

Although 2 115 (15%) persons had died, 8 189 (56%) had been discharged alive or transferred out, and 4 250 (29%) were still in hospital. Every death is a tragedy, but every person who survives is equally a triumph.

Those successes have been aided by advances in our knowledge of how we treat the sickest patients who are admitted to hospital. Two main advances are the use of the steroid dexamethasone, and alternative ways of delivering more oxygen to patients, short of intubation and mechanically aiding their breathing in the intensive care unit.

Dexamethasone is a commonly used corticosteroid (steroid) available in South Africa and across the world. Recently, results of its use in hospitalised patients with severe Covid-19 were announced by investigators of the UK RECOVERY trial, that set out to study six different possible treatments for Covid-19 at the same time, an example of an adaptive clinical trial alluded to above3.

They found that people admitted to hospital, who needed oxygen support, had a reduction in death of one fifth, and for those on a ventilator in ICU, the reduction in death was one third if they took dexamethasone daily for 10 days. There was no effect for patients who did not require oxygen. This is a major advance as it is the first medicine to show an effect on death rate in severely ill patients with Covid-19.

Another medicine, remdesivir, has been shown in a trial in the US to reduce the duration of symptoms, but did not affect the mortality. Since the publication of these results, doctors in South African hospitals have rapidly started to use these approaches, treating patients with Covid-19 who require oxygen by giving dexamethasone or an equivalent steroid to benefit the patient.

Covid-19 is first and foremost an infection of the lungs, and we are also advancing the way in which we support the sickest patients by giving greater amounts of oxygen in an attempt to reduce the need for people to be ventilated on the ICU.

Like dexamethasone, treating critically ill patients with humidified high flow nasal oxygen (HFNO) is not new, but the global experience, and now ours in South Africa, has taught us that using HFNO in the general wards as well as in the ICU, can improve survival of some patients.

Added to this, the incredibly simple understanding that nursing patients with them lying on their front (proning) also improves oxygen supply to the body. This, too, has been previously used in ICUs, but is now being employed in the wards. Some patients will still need to be ventilated on the ICU.

Despite these sickest patients having the highest risk of dying, we are seeing some patients survive and come off the ventilators to be discharged. The public perception that going into hospital invariably results in death is not the case, despite the very high numbers that do sadly succumb.

This balance in narrative that healthcare workers can provide needs to be matched with the stories of survivors of Covid-19 in South Africa. We need to hear and learn from the experiences of patients, relatives, and staff in our health services, if we are to make further improvements and gain greater insight into how best to manage Covid-19, and its place in society.

Equally, it is absolutely critical that clinical trials of new medicines and vaccines can take place in our country, so that we can ensure that they work in our setting, which is unique in so many ways.

Physical distancing and masks

We welcome the vaccine trials that are under way4, and clinical trials, such as the international World Health Organisation SOLIDARITY trial5among others, that will start shortly in South Africa, looking at new treatment options for Covid-19.

Lastly, the positive benefits of reducing coronavirus transmission by following the simple public health measures of social distancing, universal masking, hand hygiene, regular decontaminating of often-used surfaces, and isolating if symptoms develop, cannot be stressed enough.

These are truly positive rather than negative narratives, in so much as they protect our most vulnerable older populations and those with comorbid medical conditions.

An understandably nihilistic viewpoint of Covid-19, especially for the sickest of our population, needs to be balanced with the positive developments that are happening in the field.

This, coupled with the outstanding ability and dedication of the South African health workforce, gives hope for the coming months, despite the incredible challenges that we face from Covid-19.

-Marc Mendelson isProfessor of Infectious Diseases, Head of Division of Infectious Diseases & HIV Medicine atGroote Schuur Hospital,University of Cape Town and a member of the Ministerial Advisory Committee on Covid-19.

References

1. Johns Hopkins University. Covid-19 Dashboard by the Centre for Systems Science and Engineering (CSSE). Available at https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6 (Accessed on 3rd July 2020)

2. National Institute for Communicable Diseases. Covid-19 Surveillance Reports. Available at https://www.nicd.ac.za/diseases-a-z-index/covid-19/surveillance-reports/ (Accessed on 3rd July 2020)

Randomised Evaluation of Covid-19 Therapy (RECOVERY): Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of Covid-19. Availablehttps://www.recoverytrial.net/files/recovery_dexamethasone_statement_160620_v2final.pdf (Accessed on 3rd July 2020)

3. University of Witwatersrand. The first Covid-19 vaccine trial is South Africa begins. Available at http://www.wits.ac.za/covid19vaccine/ (Accessed on 3rd July 2020)

4. World Health Organisation. "Solidarity" clinical trial for Covid-19 treatments. Available at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments (Accessed on 3rd July 2020)

See the article here:

OPINION | 100 days of lockdown: Success stories need to bring some balance to Covid-19 narrative - News24

Read the Rest...

Global Medical Imaging Reagents Market to Witness Heightened Growth During the Period 2017 2025 – Jewish Life News

§ July 6th, 2020 § Filed under Quantum Medicine Comments Off on Global Medical Imaging Reagents Market to Witness Heightened Growth During the Period 2017 2025 – Jewish Life News

Medical imaging is used to define the use of conventional and sophisticated diagnostic practices. Traditional imaging techniques like computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, X-ray, and nuclear medicine (NM) usually analyze morphology and anatomy but are unable to detect changes at the molecular level. However, new developments in biotechnology allow imaging at the molecular and cellular level, making way for early diagnosis and treatment of disease. Medical imaging reagents play a very crucial role in this medical revolution.

Medical Imaging Reagents Market: Drivers and Restraints

Technological advances used in medical imaging reagents is moving forward at a rapid pace. These technologies include biologic targeting, microfluidics, nanotechnology, protein engineering and supramolecular chemistry. Rapid development across a number of technology fields promise to change the medical imaging industry by enabling novel imaging reagents and unique market opportunities. The high market growth rate for medical imaging reagents results in the adoption of personalized medicine, which demands a molecular approach toward the early diagnosis and monitoring of drugs. At the same time, the impact of enormous advances in proteomics and genomics are generating biomarkers of diseases. This rich source of biologic targets can be exploited by medical imaging reagents for detection of early plaques formed in Alzheimers disease or early detection of cancer cells.

To remain ahead of your competitors, request for a sample [emailprotected]

https://www.persistencemarketresearch.com/samples/14242

Medical Imaging Reagents Market: Segmentation

On the basis of technology, the medical imaging reagents market can be segmented into:

On the basis of application, the medical imaging reagents market can be segmented into:

On the basis of product type, the medical imaging reagents market can be segmented into:

On the basis of end user, the medical imaging reagents market can be segmented into:

In-vivo optical imaging reagents are key technologies for the drug development industry, as they allow for imaging of drug distribution and pharmacokinetics in mammalian animals. Such studies are critical in assisting pharmaceutical companies to eliminate poor drug candidates prior to expensive clinical trials.

To receive extensive list of important regions, Request Methodology here @

https://www.persistencemarketresearch.com/methodology/14242

Medical Imaging Reagents Market: Overview

Optical imaging reagents are an enabling technology in proteomics, genomics, in-vitro diagnostics industries and cellular analysis. Fluorescent dyes, probes, and proteins are essential components of the assays and techniques that are the basis for these fields of research, including DNA sequencing, polymerase chain reaction (PCR), immunoassays and cell-based fluorescence analysis. Growth in these markets will continue to drive demand for in-vitro imaging reagents. The medical imaging reagents industry is composed of a core group of companies that are leaders in life sciences R&D tools and medical imaging instrumentation. A major competitive strategy for achieving success in medical imaging reagents businesses has been acquiring unique technology in fluorescent proteins, fluorescence dyes, and probes, quantum dots, or nanotechnology. Biotechnology or nanotechnology companies are central to the development of these technologies and, thus, serve as innovative forces.

Medical Imaging Reagents Market: Region-wise Outlook

Geographically, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America dominates the medical imaging reagents market due to a rapid adoption of several types of modalities by end users, technological advancements, the prevalence of chronic diseases such as cancer, cardiovascular disease, and others. The North America market is followed by Europe and Asia-Pacific. Europe is the second largest market for medical imaging reagents due to growing health awareness among people and increasing number of research and development activities. Asia-Pacific is expected to grow at a faster pace due to rise in population, an increase in opportunity for clinical and preclinical studies at low costs, and government support for research and development activities in the medical imaging reagents market.

You Can Request for TOC Here @ https://www.persistencemarketresearch.com/toc/14242

Medical Imaging Reagents Market: Key Players

Some of the major market players include Bayer Healthcare AG, Lantheus Medical Imaging, Inc., GE Healthcare, Bracco Imaging SpA, Thermo Fisher Scientific, Inc. Mallinckrodt Pharmaceuticals, and Siemens Healthcare. A key to maintaining a competitive advantage in the future medical imaging reagents market will be to continue an aggressive strategy of acquiring novel technologies that enhance the functionality and biocompatibility of present imaging reagents.

See original here:

Global Medical Imaging Reagents Market to Witness Heightened Growth During the Period 2017 2025 - Jewish Life News

Read the Rest...

Dhaka University is in need of reinvention – The Financial Express

§ July 6th, 2020 § Filed under Quantum Medicine Comments Off on Dhaka University is in need of reinvention – The Financial Express

Syed Badrul Ahsan | Published: July 05, 2020 21:50:03

Dhaka University will be a hundred years old next year. The enthusiasm that will go into the celebrations of its centenary are already being felt, a broad hint of it being the manner in which current and former alumni cheerfully observed its 99th founding anniversary on the first day of July.

The university, for all the impediments which have come its way in recent times, remains the nation's premier institution of higher learning. Indeed, there are people who fondly refer to it as the Oxford of the East, even if that reputation has taken a good deal of battering over the years for reasons that ought to be obvious.

Certainly the greatest tribute which can be paid to Dhaka University comes associated with its past. And one of course must begin through recalling the endeavours of men like Nawab Salimullah, who remains a point of reference in any discussion of the university. Mention needs to be made too of the British colonial power, for in its annulment of the partition of Bengal in 1911, it offered the consolation of a promise of a university for eastern Bengal.

Since 1921, therefore, Dhaka University has come a long way. It has weathered many a storm, has created history at nearly every turn and has produced scholars who have gone out into the wider world seeking to disseminate the Bengali scholarly and cultural ethos across the globe.

And yet the reputation of a university rests not merely on past laurels but on present achievements. In these past many years, the placement of Bangladesh's universities among the notable institutions of higher learning on the global scale has been frustrating, for that placement has not been there at all.

It has been particularly galling for Dhaka University, indeed for those who have taken pride in its past, to be informed that it has no place in the world's intellectual spaces. Lack of research, absence of world class education, a preponderance of politics and a general sense of lethargy has appeared to undermine the university.

That leads one to a crucial point, which is that Dhaka University needs to reinvent itself. But reinvention is not a proposition that can be put into implementation mode as soon as it is mouthed. There are the difficulties along the way, if one has cared to observe the recent budget for public universities announced by the University Grants Commission. The Tk 84.85 billion e budget for 2020-21 covers 46 public universities. Of the amount, Dhaka University is the recipient of slightly over Tk 8.30 billion, which is the biggest chunk when compared to the amount handed out to the remaining 45 universities. The problem comes in with the allocation for research, in all these public universities. A mere Tk 660 million has been doled out for research in higher education.

And that indeed is where the public universities are stymied. For years academics and education experts have argued for a decent quantum of money to be thrown into research.

In fact, in an era where education should be among the topmost priorities in public planning, our schools, colleges and universities have remained on the fringes of policy considerations. Now take this Tk 660 million and try working out a scheme for research. And remember this amount is for all 46 public universities. How much of it, then, can Dhaka University expect to get for itself? And to what degree will that suffice for meaningful research for the university?

A general complaint about Dhaka University insofar as its absence on the scale of global rankings is concerned has been its sheer poverty in terms of research. The new allocation only maintains the disturbing status quo.

Yet Dhaka University needs to link its present with its past. The past, unquestionably political in nature and therefore contributory to the making of national history, was also defined by scholarly pursuits on the watch of a large number of its vice chancellors. It is on the basis of that past that the present ought to be shaped, at both the individual levels of the various departments of the university and the collective endeavours of the university as a whole.

Obviously encouraging is the presence of a vibrant presence of students, a heritage that surely must not wither way. Equally remarkable has been the crop of teachers generationally coming forth with ideas commensurate with the times. It is such energy which needs harnessing, through opening up the departments --- in the humanities, sciences, et cetera --- to explorations of newer concepts. Dhaka University is today in need of an explosion of energy that can truly restore its erstwhile reputation as the Oxford of the East.

As it enters its hundredth year, Dhaka University must catch up with the times. Good, purposeful libraries in the departments, apart from the central library of the university, equipped with the most modern works and treatises on the subjects covered by the institution are an imperative. Perhaps the time is here for the university to explore the possibilities of purposeful schools -- and here the role of the government as also of public intellectuals will be important --- in the humanities, sciences and social sciences --- being set up.

Universities are places for the pursuit of merit. Journals rich in content ---in medicine, physics, engineering, literature, politics, history, philosophy, law, international relations, et cetera --- and published periodically and regularly can only heighten the appeal of Dhaka University on a global scale. Additionally, teachers' unions and students' unions should reconfigure themselves in the larger interest of both the university administration and general students' welfare.

Dhaka University is part of history. Its glory days have covered the period from 1948 through 1952 through 1962 through 1969 and all the way to 1971. Post-liberation, it has been a powerful symbol of resistance to all manner of authoritarian politics. Its students and teachers have suffered and died in some of the darkest moments of the nation's history.

Dhaka University goes on embodying the aspirations of the nation as it lights the spark of intellectual inquiry in the young men and women who today occupy its classrooms, looking beyond the present and peering into the future.

Syed Badrul Ahsan is writer and senior journalist.

ahsan.syedbadrul@gmail.com

See the original post here:

Dhaka University is in need of reinvention - The Financial Express

Read the Rest...

Addressing the potential impact of coronavirus disease (COVID-19) on Big Data in the Healthcare & Pharmaceutical Market Top Big Data in the…

§ July 6th, 2020 § Filed under Quantum Medicine Comments Off on Addressing the potential impact of coronavirus disease (COVID-19) on Big Data in the Healthcare & Pharmaceutical Market Top Big Data in the…

Big Data originally emerged as a term to describe datasets whose size is beyond the ability of traditional databases to capture, store, manage and analyze. However, the scope of the term has significantly expanded over the years. Big Data not only refers to the data itself but also a set of technologies that capture, store, manage and analyze large and variable collections of data, to solve complex problems.

Amid the proliferation of real-time and historical data from sources such as connected devices, web, social media, sensors, log files and transactional applications, Big Data is rapidly gaining traction from a diverse range of vertical sectors. The healthcare and pharmaceutical industry is no exception to this trend, where Big Data has found a host of applications ranging from drug discovery and precision medicine to clinical decision support and population health management.

Get Free Sample PDF Copy of Report @https://www.researchmoz.us/enquiry.php?type=S&repid=1863306

SNS Telecom & IT estimates that Big Data investments in the healthcare and pharmaceutical industry will account for nearly $4.7 Billion in 2018 alone. Led by a plethora of business opportunities for healthcare providers, insurers, payers, government agencies, pharmaceutical companies and other stakeholders, these investments are further expected to grow at a CAGR of approximately 12% over the next three years.

The Big Data in the Healthcare & Pharmaceutical Industry: 2018 2030 Opportunities, Challenges, Strategies & Forecasts report presents an in-depth assessment of Big Data in the healthcare and pharmaceutical industry including key market drivers, challenges, investment potential, application areas, use cases, future roadmap, value chain, case studies, vendor profiles and strategies. The report also presents market size forecasts for Big Data hardware, software and professional services investments from 2018 through to 2030. The forecasts are segmented for 8 horizontal submarkets, 5 application areas, 37 use cases, 6 regions and 35 countries.

The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.

Topics Covered

The report covers the following topics:

Forecast Segmentation

Market forecasts are provided for each of the following submarkets and their subcategories:

Hardware, Software & Professional Services

Horizontal Submarkets

Application Areas

Use Cases

Regional Markets

Country Markets

Argentina, Australia, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany, India, Indonesia, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Norway, Pakistan, Philippines, Poland, Qatar, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Taiwan, Thailand, UAE, UK, USA

Key Questions Answered

The report provides answers to the following key questions:

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid=1863306

Key Findings

The report has the following key findings:

List of Companies Mentioned

For More Information Kindly Contact: ResearchMoz Mr. Rohit Bhisey, 90 State Street, Albany NY, United States 12207 Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email: [emailprotected] Media Release @ https://www.researchmoz.us/pressrelease Follow me on Blogger: https://trendingrelease.blogspot.com/

Continue reading here:

Addressing the potential impact of coronavirus disease (COVID-19) on Big Data in the Healthcare & Pharmaceutical Market Top Big Data in the...

Read the Rest...

2020 Insights on the Worldwide Quantum Dots Industry – The Market Will Face Significant Disruption due to COVID-19 – Yahoo Finance UK

§ July 1st, 2020 § Filed under Quantum Medicine Comments Off on 2020 Insights on the Worldwide Quantum Dots Industry – The Market Will Face Significant Disruption due to COVID-19 – Yahoo Finance UK

Dublin, June 26, 2020 (GLOBE NEWSWIRE) -- The "The Quantum Dots Report 2020 (16th Edition)" report has been added to ResearchAndMarkets.com's offering.

Quantum Dots (QDs) are used in a range of optoelectronic devices, including TVs and displays, light-emitting devices (LEDs), solar cells, photodiodes, thermoelectrics, photoconductors and field-effect transistors, while QD solutions have been used in a number of in vivo and in vitro imaging, sensing and labelling techniques.

The quantum dot market is moving towards more advanced applications of quantum dots in TVs with major producers developing technologies beyond Quantum Dot Enhancement Film (QDEF) such as:

Market segments such as micro and mini LEDs, sensors, lighting, solar windows, anti-counterfeiting and biosciences offer excellent opportunities. The Global Market for Quantum Dots analyses quantum dot suppliers, display manufacturers and OEMs. The global quantum dots (QD) based products market will be potentially valued at more than $35 billion by 2030. The optoelectronics market represents the vast majority of this figure, chiefly High Definition TVs-QLED-TVs. However, the market will face significant disruption this year in terms of manufacturing, supply chain and consumer demand due to the impact of the COVID-19 pandemic.

TV displays still dominate the end-user segment for QD-based products with a fast-growing market for QD monitors. The use of QDs in solar conversion windows is also being heavily backed this year with a number of companies developing prototypes and funding multi-million dollar investments. The price of large QD-TVs is also falling.

This 230 page analysis report on the quantum dots market is now in its 16th edition (First edition 2009) and provides a more in-depth analysis of the HDTV segment and emerging markets for quantum dots, graphene quantum dots and perovskite quantum dots plus a new QD Roadmap.

Contents include:

Key Topics Covered:

1 Executive Summary

2 Research Scope and Methodology

3 Quantum Dots-Properties, Synthesis, Types 3.1 Properties 3.2 Synthesis 3.3 Types 3.3.1 Cadmium Selenide, Cadmium Sulfide and other materials 3.3.2 Cadmium free quantum dots 3.4 Carbon quantum dots (CDs) 3.4.1 Properties 3.4.2 Applications 3.5 Graphene quantum dots (GQDs) 3.5.1 Properties 3.5.2 Synthesis 3.5.3 Applications 3.5.3.1 Pricing 3.6 Perovskite quantum dots (PQDs) 3.6.1 Properties 3.6.2 Comparison to conventional quantum dots 3.6.3 Synthesis methods 3.6.4 Applications 3.6.4.1 Displays 3.6.5 Producers 3.7 Quantum rods 3.7.1 Properties 3.7.2 Applications

4 Quantum Dots Technology Readiness

5 Quantum Dots Industry Analysis 5.1 Licensing, collaborations and partnerships 5.2 Supply chain

6 Quantum Dots Regulations 6.1 Europe 6.1.1 Cadmium exemption in TVs and lighting 6.1.2 August 2017 ruling 6.2 United States 6.3 Asia

7 Global Market Revenues for Quantum Dots 7.1 Revenues 2013-2030

8 Quantum Dots in Tvs/Displays 8.1 Market drivers and trends 8.2 LCDS vs. OLEDs vs. QD-LCDs/QLEDs 8.2.1 Liquid Crystal Displays (LCD) 8.3 QD-LCD TVs/QLEDs 8.4 Quantum dot enhancement film (QDEF) for current QLEDs 8.5 Quantum Dot on Glass (QDOG) 8.6 Quantum dot colour filters 8.7 Quantum dots on-chip 8.8 Electroluminescent quantum dots 8.8.1 QD-Micro-LEDs 8.9 Flexible QD displays 8.9.1 Flexible QLEDs 8.10 LG Nanocell 8.11 Industry and research developments 2013-2019 8.12 Global market for quantum dots in TVs and displays 8.12.1 QD-TV unit sales 2016-2030 8.12.2 QD TV Unit sales, adjusted for COVID-19 market scenarios to 2025 8.12.3 QD Monitor Unit sales 2015-2030 8.12.4 QD Monitor Unit sales, adjusted for COVID-19 market scenarios to 2025

9 Quantum Dots in Photovoltaics 9.1 Market drivers and trends 9.2 Applications 9.2.1 Nanomaterials in solar cells 9.2.2 Advantages of quantum dots in photovoltaics 9.2.3 Types of quantum dot solar cells 9.2.3.1 Metal - semiconductor/ Schottky QD junction solar cell 9.2.3.2 Silicon/QD Film Hydrid Solar Cells 9.2.3.3 Silicon/Graphene QD Film Hydrid Solar Cells 9.2.3.4 Depleted-heterojunction QD solar cell 9.2.3.5 QD-sensitized solar cells (QDSSC) 9.2.3.6 Quantum dot solar windows 9.3 Market challenges 9.4 Industry and research developments 2013-2019 9.5 Global market for quantum dots in photovoltaics 9.5.1 QD photovoltaics revenues, adjusted for COVID-19 market scenarios to 2025 9.6 Quantum dot photovoltaics companies

10 Quantum Dots in Lighting 10.1 Market drivers and trends 10.2 Applications 10.2.1 LED lighting 10.2.2 Horticultural lighting and greenhouse films 10.3 Market challenges 10.4 Industry and research developments 2013-2019 10.5 Global market for quantum dots in LED lighting 10.5.1 QD lighting revenues, adjusted for COVID-19 market scenarios to 2025 10.6 Quantum dot lighting companies

Story continues

11 Quantum Dots in Biotech and Medicine 11.1 Market drivers and trends 11.2 Applications 11.2.1 Imaging and diagnostics 11.2.1.1 Advantages 11.2.1.2 Biomarkers 11.2.1.3 Photodynamic therapy 11.2.1.4 Point-of-care 11.2.2 Drug delivery 11.2.3 Photodynamic therapy 11.3 Market challenges 11.4 Global market for quantum dots in biotechnology and medicine 11.4.1 Imaging and diagnostics 11.4.2 Drug delivery 11.5 QD biotech and medicine revenues, adjusted for COVID-19 market scenarios to 2025 11.6 Quantum dot biotechnology and medicine companies

12 Quantum Dots in Security and Anti-Counterfeiting 12.1 Market drivers and trends 12.2 Applications 12.3 Global market size for quantum dots in security and anti-counterfeiting 12.3.1 QD anti-counterfeiting and security revenues, adjusted for COVID-19 market scenarios to 2025 12.4 Quantum dot security and anti-counterfeiting Companies

13 Quantum Dots in Sensors 13.1 Market drivers and trends 13.2 Applications 13.2.1 Food sensors 13.2.2 Chemical and gas sensors 13.2.3 Biosensors 13.2.4 Image sensors 13.3 Global market size for quantum dots in sensors 13.3.1 QD sensors revenues, adjusted for COVID-19 market scenarios to 2025 13.4 Market challenges 13.5 Quantum dot sensor companies

14 Other Markets 14.1 Batteries 14.1.1 Properties 14.1.2 Companies 14.2 Thermoelectrics 14.2.1 Properties 14.2.2 Companies 14.3 QD Lasers 14.3.1 Companies 14.4 Photocatalysts 14.5 Spectrometers 14.6 Computing 14.7 Hydrogen production 14.8 Autonomous vehicles

15 Quantum Dot Producer and Product Developer Profiles

16 References

For more information about this report visit https://www.researchandmarkets.com/r/5c7hhd

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

See the original post:

2020 Insights on the Worldwide Quantum Dots Industry - The Market Will Face Significant Disruption due to COVID-19 - Yahoo Finance UK

Read the Rest...

Rare Disease Diagnostics Industry Anticipated to Reach $26.7 Billion by 2024 – Market Shares by Disease Class, Indication, Analysis Platform, Analysis…

§ July 1st, 2020 § Filed under Quantum Medicine Comments Off on Rare Disease Diagnostics Industry Anticipated to Reach $26.7 Billion by 2024 – Market Shares by Disease Class, Indication, Analysis Platform, Analysis…

DUBLIN, July 1, 2020 /PRNewswire/ -- The "Rare Disease Diagnostics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

The global rare disease diagnostics market should reach $26.7 billion by 2024 from $17 billion in 2019, rising at a CAGR of 9.5% over the forecast period.

The scope of the report includes rare disease diagnostic technologies, applications, industries, initiatives, patents and companies. The market for rare disease diagnostic products and services is given for 2018 and 2019, and then forecast through 2024.

This report reviews the main diagnostic technologies and explains why genetic variation is important in clinical testing and disease. It then discusses significant large-scale research initiatives that impact rare disease diagnostic applications. Of particular interest is a discussion of global population-scale sequencing projects and their likely impact in linking genetic variation to rare disease diagnostics. The main market driving forces for rare disease diagnostic products and services are listed and discussed.

The report categorizes and quantifies the rare disease diagnostics market by the disease category, technology platform, test purpose, analysis target and geography segments.

More than 95 companies in the rare disease diagnostic industry are profiled in this report.

The research also provides a summary of more than 50 of the main industry acquisitions and strategic alliances that took place from April 2018 through April 2020, including key alliance trends.

The report includes:

Market Insights

Rare diseases comprise a growing public health priority, as they affect upward of 300 million people globally and they are difficult to diagnose and treat.

There is a pressing need for better ways to detect and diagnose rare diseases, as well as to provide companion diagnostics for therapy guidance, clinical trials enrollment and therapy monitoring applications.

Better diagnostic tests for rare diseases can make significant differences in the lives of those affected by these conditions. Many rare diseases go undiagnosed for long periods of time because patients, families and physicians may have limited awareness of certain diseases, and the symptoms may not be informative to healthcare workers who may not have encountered such diseases before.

Extended time to diagnosis of a rare disease, along with so-called diagnostic odysseys, can lead to negative outcomes, including misdiagnosis or disease progression. Rapid, accurate diagnostics can significantly shorten these diagnostic odysseys.

In addition to early detection and diagnostic potential, rare disease therapeutics will be important in orphan drug development and use. Orphan drugs address rare disease patient populations, and they are expected to have a high growth rate through 2024. By 2024, orphan drugs may make up as much as one-fifth of global prescription sales. Rare disease diagnostics can be used to help physicians make proper decisions regarding which therapies to use and ways to monitor the efficacy of those therapies during treatment courses. Rare disease diagnostics can also be used to help select patients for orphan drug clinical trials.

More than 70% of rare diseases are inherited conditions, and they thus have genetic components, so this industry relies heavily on genetic analysis methods, including polymerase chain reaction (PCR), next-generation sequencing (NGS) and Sanger sequencing.

Key Topics Covered

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Overview

Chapter 4 Technology Background

Chapter 5 Rare Disease Diagnostics Initiatives

Chapter 6 Rare Disease Diagnostic Industries

Chapter 7 Rare Disease Diagnostics Strategic Alliances and Acquisitions

Chapter 8 Rare Disease Diagnostics Markets

Chapter 9 Rare Disease Diagnostics Patents and Intellectual Property

Chapter 10 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/rp6ok6

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

Continued here:

Rare Disease Diagnostics Industry Anticipated to Reach $26.7 Billion by 2024 - Market Shares by Disease Class, Indication, Analysis Platform, Analysis...

Read the Rest...

Over 4 Million Computers Worldwide Joined Folding@home to Aid in Coronavirus Research – HPCwire

§ July 1st, 2020 § Filed under Quantum Medicine Comments Off on Over 4 Million Computers Worldwide Joined Folding@home to Aid in Coronavirus Research – HPCwire

June 26, 2020 When the crowdsourced supercomputing project [emailprotected]first announced a shift to coronavirus research and asked for new volunteers to run its software and expand its computing capacity, organizations and citizen scientists from all walks of life heeded the call. Now, about four months later, the number of volunteers has increased a hundredfold.

Based at Washington University School of Medicine in St. Louis, the computing project simulates the movements or folding of proteins involved in disease. Researchers leading the effort pivoted quickly to COVID-19 and found a wealth of people eager to help. Before the switch to the novel coronavirus, about 30,000 devices were running [emailprotected] software. With the prospect of contributing to coronavirus research, new volunteer folders have boosted that number to over 4 million to date, with major companies and organizations eager to donate their own computing resources to the cause.

Organizations and technology companies such as Microsoft, Avast, Amazon Web Services, Pure Storage, AMD (Advanced Micro Devices), VMware, Cisco and Oracle are all supporting the project. Microsofts AI (artificial intelligence) for Health initiative has donated computing space in Microsoft Azure, the companys cloud computing system. Other contributors include CERN, the European Organization for Nuclear Research, which runs the Large Hadron Collider, the worlds most powerful particle accelerator.

Many of the companies lending support are involved with computer technology, including those that make graphics cards for video gaming, antivirus software and cloud computing systems. But even pro sports have jumped in to help. La Liga, the Spanish professional soccer league, shifted the use of its supercomputer from a focus on catching illegal broadcasts of games the leagues soccer matches were halted during the peak of the pandemic to a focus on protein folding.

Weve got an incredible community here and out in the world contributing to the scientific process of understanding this virus, saidGreg Bowman, PhD, of Washington University School of Medicine, who leads [emailprotected] The outpouring of support has been extraordinary.

Among those heavily involved in the project isWashington Universitys Office of Information Technology, which is helping manage the [emailprotected] servers and has deployed the software on many desktops across campus that have been sidelined while faculty, staff and students telecommute to help stop the spread of the virus.

The project relies on the combined processing power of volunteers home computers to perform the billions of calculations required to simulate how proteins move. Understanding how they move or fold into their characteristic shapes can reveal how they work. It also can uncover ways to interfere with harmful proteins.

With the focus on COVID-19, Bowman and his collaborators are working to understand the proteins that allow the novel coronavirus to invade cells, multiply and spread. That knowledge could lead to new treatments.

Were basically building maps of what these viral proteins can do, said Bowman, also an associate professor of biochemistry and molecular biophysics at the School of Medicine. If we compare this to maps of cities and towns, this map would show protein structures.

We dont have a way to take a satellite image of this area we would like to map, he said. Instead, were trying to build this map by having lots of people run simulations on their separate computers and send us back the data. In the map analogy, this is like having people around the globe jump in their cars and drive around their local neighborhoods and send us back their GPS coordinates at regular intervals. If we can develop detailed maps of these important viral proteins, we can identify the best drug compounds or antibodies to interfere with the virus and its ability to infect and spread.

Calculations on this scale require tremendous computing power. With the surge of new participants, [emailprotected]s distributed computing network now has more raw computing power than the worlds largest 500 traditional supercomputers combined.

[emailprotected] also recently received a grant from the National Science Foundation (NSF) called a RAPID award, which provides funding quickly to researchers studying SARS-CoV-2, the virus that causes COVID-19. Past RAPID awards have focused on Ebola and Zika viruses and improving responses to disasters such as major hurricanes and oil spills.

In the spirit of open science and the quick dissemination of crowdsourced research about COVID-19, the [emailprotected] team will share their data in public databases and publish their findings on free and open-access preprint sites, such as bioRxiv.

To download the [emailprotected] software and start contributing to COVID-19 research, visithttps://foldingathome.org/start-folding/.

About the Washington University School of Medicine

Washington University School of Medicines 1,500 faculty physicians also are the medical staff ofBarnes-JewishandSt. Louis Childrenshospitals. The School of Medicine is a leader in medical research, teaching and patient care, ranking among the top 10 medical schools in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Childrens hospitals, the School of Medicine is linked toBJC HealthCare.

Source: Julia Evangelou Strait, Washington University School of Medicine

Originally posted here:

Over 4 Million Computers Worldwide Joined Folding@home to Aid in Coronavirus Research - HPCwire

Read the Rest...

17 ways technology could change the world by 2025 – The European Sting

§ June 24th, 2020 § Filed under Quantum Medicine Comments Off on 17 ways technology could change the world by 2025 – The European Sting

(Credit: Unsplash)

This article is brought to you thanks to the collaboration ofThe European Stingwith theWorld Economic Forum.

Author: Saemoon Yoon, Community Lead, Technology Pioneers, World Economic Forum Geneva

We asked our 2020 intake of Technology Pioneers for their views on how technology will change the world in the next five years.

1. AI-optimized manufacturing

Paper and pencil tracking, luck, significant global travel and opaque supply chains are part of todays status quo, resulting in large amounts of wasted energy, materials and time. Accelerated in part by the long-term shutdown of international and regional travel by COVID-19, companies that design and build products will rapidly adopt cloud-based technologies to aggregate, intelligently transform, and contextually present product and process data from manufacturing lines throughout their supply chains. By 2025, this ubiquitous stream of data and the intelligent algorithms crunching it will enable manufacturing lines to continuously optimize towards higher levels of output and product quality reducing overall waste in manufacturing by up to 50%. As a result, we will enjoy higher quality products, produced faster, at lower cost to our pocketbooks and the environment.

Anna-Katrina Shedletsky, CEO and Founder of Instrumental

2. A far-reaching energy transformation

In 2025, carbon footprints will be viewed as socially unacceptable, much like drink driving is today. The COVID-19 pandemic will have focused the publics attention on the need to take action to deal with threats to our way of life, our health and our future. Public attention will drive government policy and behavioural changes, with carbon footprints becoming a subject of worldwide scrutiny. Individuals, companies and countries will seek the quickest and most affordable ways to achieve net-zero the elimination of their carbon footprint. The creation of a sustainable, net-zero future will be built through a far-reaching energy transformation that significantly reduces the worlds carbon emissions, and through the emergence of a massive carbon management industry that captures, utilizes and eliminates carbon dioxide. Well see a diversity of new technologies aimed at both reducing and removing the worlds emissions unleashing a wave of innovation to compare with the industrial and digital Revolutions of the past.

Steve Oldham, CEO of Carbon Engineering

3. A new era of computing

By 2025, quantum computing will have outgrown its infancy, and a first generation of commercial devices will be able tackle meaningful, real-world problems. One major application of this new kind of computer will be the simulation of complex chemical reactions, a powerful tool that opens up new avenues in drug development. Quantum chemistry calculations will also aid the design of novel materials with desired properties, for instance better catalysts for the automotive industry that curb emissions and help fight climate change. Right now, the development of pharmaceuticals and performance materials relies massively on trial and error, which means it is an iterative, time-consuming and terribly expensive process. Quantum computers may soon be able to change this. They will significantly shorten product development cycles and reduce the costs for R&D.

Thomas Monz, Co-Founder and CEO of Alpine Quantum Technologies

4. Healthcare paradigm shift to prevention through diet

By 2025, healthcare systems will adopt more preventative health approaches based on the developing science behind the health benefits of plant-rich, nutrient-dense diets. This trend will be enabled by AI-powered and systems biology-based technology that exponentially grows our knowledge of the role of specific dietary phytonutrients in specific human health and functional outcomes. After the pandemic of 2020, consumers will be more aware of the importance of their underlying health and will increasingly demand healthier food to help support their natural defences. Armed with a much deeper understanding of nutrition, the global food industry can respond by offering a broader range of product options to support optimal health outcomes. The healthcare industry can respond by promoting earths plant intelligence for more resilient lives and to incentivize people to take care of themselves in an effort to reduce unsustainable costs.

Jim Flatt, Co-Founder and CEO of Brightseed

5. 5G will enhance the global economy and save lives

Overnight, weve experienced a sharp increase in delivery services with a need for day-of goods from providers like Amazon and Instacart but it has been limited. With 5G networks in place, tied directly into autonomous bots, goods would be delivered safely within hours.

Wifi cant scale to meet higher capacity demands. Sheltering-in-place has moved businesses and classrooms to video conferencing, highlighting poor-quality networks. Low latency 5G networks would resolve this lack of network reliability and even allow for more high-capacity services like telehealth, telesurgery and ER services. Businesses can offset the high cost of mobility with economy-boosting activities including smart factories, real-time monitoring, and content-intensive, real-time edge-compute services. 5G private networks make this possible and changes the mobile services economy.

The roll-out of 5G creates markets that we only imagine like self-driving bots, along with a mobility-as-a-service economy and others we cant imagine, enabling next generations to invent thriving markets and prosperous causes.

Maha Achour, Founder and CEO of Metawave

6. A new normal in managing cancer

Technology drives data, data catalyzes knowledge, and knowledge enables empowerment. In tomorrows world, cancer will be managed like any chronic health condition we will be able to precisely identify what we may be facing and be empowered to overcome it.

In other words, a new normal will emerge in how we can manage cancer. We will see more early and proactive screening with improved diagnostics innovation, such as in better genome sequencing technology or in liquid biopsy, that promises higher ease of testing, higher accuracy and ideally at an affordable cost. Early detection and intervention in common cancer types will not only save lives but reduce the financial and emotional burden of late discovery.

We will also see a revolution in treatment propelled by technology. Gene editing and immunotherapy that bring fewer side effects will have made greater headway. With advances in early screening and treatment going hand in hand, cancer will no longer be the cursed C word that inspires such fear among people.

Sizhen Wang, CEO of Genetron Health

Historically, robotics has turned around many industries, while a few select sectors such as grocery retail have remained largely untouched . With the use of a new robotics application called microfulfillment, Grocery retailing will no longer look the same. The use of robotics downstream at a hyper local level (as opposed to the traditional upstream application in the supply chain) will disrupt this 100-year-old, $5 trillion industry and all its stakeholders will experience significant change. Retailers will operate at a higher order of magnitude on productivity, which will in turn result in positive and enticing returns in the online grocery business (unheard of at the moment). This technology also unlocks broader access to food and a better customer proposition to consumers at large: speed, product availability and cost. Microfulfillment centers are located in existing (and typically less productive) real estate at the store level and can operate 5-10% more cheaply than a brick and mortar store. We predict that value will be equally captured by retailers and consumers as online.

Jose Aguerrevere, Co-Founder, Chairman and CEO of Takeoff Technologies

8. A blurring of physical and virtual spaces

One thing the current pandemic has shown us is how important technology is for maintaining and facilitating communication not simply for work purposes, but for building real emotional connections. In the next few years we can expect to see this progress accelerate, with AI technology built to connect people at a human level and drive them closer to each other, even when physically theyre apart. The line between physical space and virtual will forever be blurred. Well start to see capabilities for global events from SXSW to the Glastonbury Festival to provide fully digitalized alternatives, beyond simple live streaming into full experiences. However, its not as simple as just providing these services data privacy will have to be prioritised in order to create confidence among consumers. At the beginning of the COVID-19 pandemic we saw a lot in the news about concerns over the security of video conferencing companies. These concerns arent going anywhere and as digital connectivity increases, brands simply cant afford to give users anything less than full transparency and control over their data.

Tugce Bulut, CEO of Streetbees

9. Putting individuals not institutions at the heart of healthcare

By 2025, the lines separating culture, information technology and health will be blurred. Engineering biology, machine learning and the sharing economy will establish a framework for decentralising the healthcare continuum, moving it from institutions to the individual. Propelling this forward are advances in artificial intelligence and new supply chain delivery mechanisms, which require the real-time biological data that engineering biology will deliver as simple, low-cost diagnostic tests to individuals in every corner of the globe. As a result, morbidity, mortality and costs will decrease in acute conditions, such as infectious diseases, because only the most severe cases will need additional care. Fewer infected people will leave their homes, dramatically altering disease epidemiology while decreasing the burden on healthcare systems. A corresponding decrease in costs and increase in the quality of care follows, as inexpensive diagnostics move expenses and power to the individual, simultaneously increasing the cost-efficiency of care. Inextricable links between health, socio-economic status and quality of life will begin to loosen, and tensions that exist by equating health with access to healthcare institutions will dissipate. From daily care to pandemics, these converging technologies will alter economic and social factors to relieve many pressures on the global human condition.

Rahul Dhanda, Co-Founder and CEO of Sherlock Biosciences

10. The future of construction has already begun

Construction will become a synchronized sequence of manufacturing processes, delivering control, change and production at scale. It will be a safer, faster and more cost-effective way to build the homes, offices, factories and other structures we need to thrive in cities and beyond. As rich datasets are created across the construction industry through the internet of things, AI and image capture, to name a few, this vision is already coming to life. Using data to deeply understand industry processes is profoundly enhancing the ability of field professionals to trust their instincts in real-time decision making, enabling learning and progress while gaining trust and adoption.

Actionable data sheds light where we could not see before, empowering leaders to manage projects proactively rather than reactively. Precision in planning and execution enables construction professionals to control the environment, instead of it controlling them, and creates repeatable processes that are easier to control, automate, and teach.

Thats the future of construction. And its already begun.

Meirav Oren, CEO and Co-Founder of Versatile

11. Gigaton-scale CO2 removal will help to reverse climate change

A scale up of negative emission technologies, such as carbon dioxide removal, will remove climate-relevant amounts of CO2 from the air. This will be necessary in order to limit global warming to 1.5C. While humanity will do everything possible to stop emitting more carbon into the atmosphere, it will also do everything it can in order to remove historic CO2 from the air permanently. By becoming widely accessible, the demand for CO2 removal will increase and costs will fall. CO2 removal will be scaled up to the gigaton-level, and will become the responsible option for removing unavoidable emissions from the air. It will empower individuals to have a direct and climate-positive impact on the level of CO2 in the atmosphere. It will ultimately help to prevent global warming from reaching dangerous levels and give humanity the potential to reverse climate change.

Jan Wurzbacher, Co-Founder and co-CEO of Climeworks

12. A new era in medicine

Medicine has always been on a quest to gather more knowledge and understanding of human biology for better clinical decision-making. AI is that new tool that will enable us to extract more insights at an unprecedented level from all the medical big data that has never really been fully taken advantage of in the past. It will shift the world of medicine and how it is practiced.

Brandon Suh, CEO of Lunit

13. Closing the wealth gap

Improvements in AI will finally put access to wealth creation within reach of the masses. Financial advisors, who are knowledge workers, have been the mainstay of wealth management: using customized strategies to grow a small nest egg into a larger one. Since knowledge workers are expensive, access to wealth management has often meant you already need to be wealthy to preserve and grow your wealth. As a result, historically, wealth management has been out of reach of those who needed it most. Artificial intelligence is improving at such a speed that the strategies employed by these financial advisors will be accessible via technology, and therefore affordable for the masses. Just like you dont need to know how near-field communication works to use ApplePay, tens of millions of people wont have to know modern portfolio theory to be able to have their money work for them.

Atish Davda, Co-Founder and CEO of Equityzen

14. A clean energy revolution supported by digital twins

Over the next five years, the energy transition will reach a tipping point. The cost of new-build renewable energy will be lower than the marginal cost of fossil fuels. A global innovation ecosystem will have provided an environment in which problems can be addressed collectively, and allowed for the deployment of innovation to be scaled rapidly. As a result, we will have seen an astounding increase in offshore wind capacity. We will have achieved this through an unwavering commitment to digitalization, which will have gathered a pace that aligns with Moores law to mirror solars innovation curve. The rapid development of digital twins virtual replicas of physical devices will support a systems-level transformation of the energy sector. The scientific machine learning that combines physics-based models with big data will lead to leaner designs, lower operating costs and ultimately clean, affordable energy for all. The ability to monitor structural health in real-time and fix things before they break will result in safer, more resilient infrastructure and everything from wind farms to bridges and unmanned aerial vehicles being protected by a real-time digital twin.

Thomas Laurent, CEO of Akselos

15. Understanding the microscopic secrets hidden on surfaces

Every surface on Earth carries hidden information that will prove essential for avoiding pandemic-related crises, both now and in the future. The built environment, where humans spend 90% of their lives, is laden with naturally occurring microbiomes comprised of bacterial, fungal and viral ecosystems. Technology that accelerates our ability to rapidly sample, digitalize and interpret microbiome data will transform our understanding of how pathogens spread. Exposing this invisible microbiome data layer will identify genetic signatures that can predict when and where people and groups are shedding pathogens, which surfaces and environments present the highest transmission risk, and how these risks are impacted by our actions and change over time. We are just scratching the surface of what microbiome data insights offer and will see this accelerate over the next five years. These insights will not only help us avoid and respond to pandemics, but will influence how we design, operate and clean environments like buildings, cars, subways and planes, in addition to how we support economic activity without sacrificing public health.

Jessica Green, Co-Founder and CEO of Phylagen

16. Machine learning and AI expedite decarbonization in carbon-heavy industries

Over the next five years, carbon-heavy industries will use machine learning and AI technology to dramatically reduce their carbon footprint. Traditionally, industries like manufacturing and oil and gas have been slow to implement decarbonization efforts as they struggle to maintain productivity and profitability while doing so. However, climate change, as well as regulatory pressure and market volatility, are pushing these industries to adjust. For example, oil and gas and industrial manufacturing organizations are feeling the pinch of regulators, who want them to significantly reduce CO2 emissions within the next few years. Technology-enabled initiatives were vital to boosting decarbonizing efforts in sectors like transportation and buildings and heavy industries will follow a similar approach. Indeed, as a result of increasing digital transformation, carbon-heavy sectors will be able to utilize advanced technologies, like AI and machine learning, using real-time, high-fidelity data from billions of connected devices to efficiently and proactively reduce harmful emissions and decrease carbon footprints.

David King, CEO of FogHorn Systems

17. Privacy is pervasive and prioritized

Despite the accelerating regulatory environments weve seen surface in recent years, we are now just seeing the tip of the privacy iceberg, both from a regulatory and consumer standpoint. Five years from now, privacy and data-centric security will have reached commodity status and the ability for consumers to protect and control sensitive data assets will be viewed as the rule rather than the exception. As awareness and understanding continue to build, so will the prevalence of privacy preserving and enhancing capabilities, namely privacy-enhancing technologies (PET). By 2025, PET as a technology category will become mainstream. They will be a foundational element of enterprise privacy and security strategies rather than an added-on component integrated only meet a minimum compliance threshold. While the world will still lack a global privacy standard, organizations will embrace a data-centric approach to security that provides the flexibility necessary to adapt to regional regulations and consumer expectations. These efforts will be led by cross-functional teams representing the data, privacy and security interests within an organization.

Ellison Anne Williams, Founder and CEO of Enveil

How will technology change the world in the next five years?

It is very exciting to see the pace and transformative potential of todays innovative technologies being applied to solve the worlds most pressing problems, such as feeding a global and growing population; improving access to and quality of healthcare; and significantly reducing carbon emissions to arrest the negative effects of climate change. The next five years will see profound improvements in addressing these challenges as entrepreneurs, the investment community and the worlds largest enterprise R&D organizations focus on developing and deploying solutions that will deliver tangible results.

While the COVID-19 pandemic has provided a difficult lesson in just how susceptible our world is today to human and economic turmoil, it has also perhaps for the first time in history necessitated global collaboration, data transparency and speed at the highest levels of government in order to minimize an immediate threat to human life. History will be our judge, but despite the heroic resolve and resiliency on a country by country basis, as a world we have underperformed. As a global community and through platforms like the World Economic Forum, we must continue to bring visibility to these issues while recognizing and supporting the opportunities for technology and innovation that can best and most rapidly address them.

Continue reading here:

17 ways technology could change the world by 2025 - The European Sting

Read the Rest...

Teleportation Is Indeed Possible At Least in the Quantum World – SciTechDaily

§ June 24th, 2020 § Filed under Quantum Medicine Comments Off on Teleportation Is Indeed Possible At Least in the Quantum World – SciTechDaily

Quantum teleportation is an important step in improving quantum computing.

Beam me up is one of the most famous catchphrases from the Star Trek series. It is the command issued when a character wishes to teleport from a remote location back to the Starship Enterprise.

While human teleportation exists only in science fiction, teleportation is possible in the subatomic world of quantum mechanicsalbeit not in the way typically depicted on TV. In the quantum world, teleportation involves the transportation of information, rather than the transportation of matter.

Last year scientists confirmed that information could be passed between photons on computer chips even when the photons were not physically linked.

Now, according to new research from the University of Rochester and Purdue University, teleportation may also be possible between electrons.

A quantum processor semiconductor chip is connected to a circuit board in the lab of John Nichol, an assistant professor of physics at the University of Rochester. Nichol and Andrew Jordan, a professor of physics, are exploring new ways of creating quantum-mechanical interactions between distant electrons, promising major advances in quantum computing. Credit: University of Rochester photo / J. Adam Fenster

In a paper published in Nature Communications and one to appear in Physical Review X, the researchers, including John Nichol, an assistant professor of physics at Rochester, and Andrew Jordan, a professor of physics at Rochester, explore new ways of creating quantum-mechanical interactions between distant electrons. The research is an important step in improving quantum computing, which, in turn, has the potential to revolutionize technology, medicine, and science by providing faster and more efficient processors and sensors.

Quantum teleportation is a demonstration of what Albert Einstein famously called spooky action at a distancealso known as quantum entanglement. In entanglementone of the basic of concepts of quantum physicsthe properties of one particle affect the properties of another, even when the particles are separated by a large distance. Quantum teleportation involves two distant, entangled particles in which the state of a third particle instantly teleports its state to the two entangled particles.

Quantum teleportation is an important means for transmitting information in quantum computing. While a typical computer consists of billions of transistors, called bits, quantum computers encode information in quantum bits, or qubits. A bit has a single binary value, which can be either 0 or 1, but qubits can be both 0 and 1 at the same time. The ability for individual qubits to simultaneously occupy multiple states underlies the great potential power of quantum computers.

Scientists have recently demonstrated quantum teleportation by using electromagnetic photons to create remotely entangled pairs of qubits.

Qubits made from individual electrons, however, are also promising for transmitting information in semiconductors.

Individual electrons are promising qubits because they interact very easily with each other, and individual electron qubits in semiconductors are also scalable, Nichol says. Reliably creating long-distance interactions between electrons is essential for quantum computing.

Creating entangled pairs of electron qubits that span long distances, which is required for teleportation, has proved challenging, though: while photons naturally propagate over long distances, electrons usually are confined to one place.

In order to demonstrate quantum teleportation using electrons, the researchers harnessed a recently developed technique based on the principles of Heisenberg exchange coupling. An individual electron is like a bar magnet with a north pole and a south pole that can point either up or down. The direction of the polewhether the north pole is pointing up or down, for instanceis known as the electrons magnetic moment or quantum spin state. If certain kinds of particles have the same magnetic moment, they cannot be in the same place at the same time. That is, two electrons in the same quantum state cannot sit on top of each other. If they did, their states would swap back and forth in time.

The researchers used the technique to distribute entangled pairs of electrons and teleport their spin states.

We provide evidence for entanglement swapping, in which we create entanglement between two electrons even though the particles never interact, and quantum gate teleportation, a potentially useful technique for quantum computing using teleportation, Nichol says. Our work shows that this can be done even without photons.

The results pave the way for future research on quantum teleportation involving spin states of all matter, not just photons, and provide more evidence for the surprisingly useful capabilities of individual electrons in qubit semiconductors.

References:

Conditional teleportation of quantum-dot spin states by Haifeng Qiao, Yadav P. Kandel, Sreenath K. Manikandan, Andrew N. Jordan, Saeed Fallahi, Geoffrey C. Gardner, Michael J. Manfra and John M. Nichol, 15 June 2020, Nature Communications. DOI: 10.1038/s41467-020-16745-0

Coherent multi-spin exchange in a quantum-dot spin chain by Haifeng Qiao, Yadav P. Kandel, Kuangyin Deng, Saeed Fallahi, Geoffrey C. Gardner, Michael J. Manfra, Edwin Barnes, John M. Nichol, Accepted 12 May 2020, Physical Review X. arXiv: 2001.02277

Read more:

Teleportation Is Indeed Possible At Least in the Quantum World - SciTechDaily

Read the Rest...

Complementary and Alternative Medicine Market Overview with Detailed Analysis, C – News.MarketSizeForecasters.com

§ June 24th, 2020 § Filed under Quantum Medicine Comments Off on Complementary and Alternative Medicine Market Overview with Detailed Analysis, C – News.MarketSizeForecasters.com

Global Complementary and Alternative Medicine Industry market analysis mainly introduces the changing market dynamics in terms of covering all details inside analysis and opinion, volume and value market share by players, by regions, by product type, by consumers and their price change details, cost/revenue structure. Additionally, the analysis of Global Complementary and Alternative Medicine Industry offers a detailed breakdown of key market growth drivers and limitation along with impact analysis of the same.

The Complementary and Alternative Medicine Industry market research report offers an exhaustive analysis of this business space. The key trends that define the Complementary and Alternative Medicine Industry market during the analysis timeframe are mentioned in the report, alongside other factors such as regional scope and regulatory outlook. Also, the document elaborates on the impact of current industry trends on key market driving factors as well as top challenges.

Request a sample Report of Complementary and Alternative Medicine Industry Market at:https://www.marketstudyreport.com/request-a-sample/2735759

The study also provides with a summary of the competitive spectrum as well as an in-depth assessment of the raw materials and downstream buyers.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

Our study helps to acquire the following:

Elaborating on the competitive landscape of Complementary and Alternative Medicine Industry market:

A gist of the regional scope of the Complementary and Alternative Medicine Industry market:

Ask for Discount on Complementary and Alternative Medicine Industry Market Report at:https://www.marketstudyreport.com/check-for-discount/2735759

Other information mentioned in the Complementary and Alternative Medicine Industry market report:

The report answers important questions that companies may have when operating in the global Complementary and Alternative Medicine Industry market. Some of the questions are given below:

For More Details On this Report: https://www.marketstudyreport.com/reports/covid-19-outbreak-global-complementary-and-alternative-medicine-industry-market-report-development-trends-threats-opportunities-and-competitive-landscape-in-2020

Related Reports:

1. COVID-19 Outbreak-Global Smart Syringes Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020 Read More: https://www.marketstudyreport.com/reports/covid-19-outbreak-global-smart-syringes-industry-market-report-development-trends-threats-opportunities-and-competitive-landscape-in-2020

2. COVID-19 Outbreak-Global Thymosin Alpha-1 Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020 Read More: https://www.marketstudyreport.com/reports/covid-19-outbreak-global-thymosin-alpha-1-industry-market-report-development-trends-threats-opportunities-and-competitive-landscape-in-2020

Contact Us: Corporate Sales, Market Study Report LLC Phone: 1-302-273-0910 Toll Free: 1-866-764-2150 Email: [emailprotected]

See original here:

Complementary and Alternative Medicine Market Overview with Detailed Analysis, C - News.MarketSizeForecasters.com

Read the Rest...

Alternative And Complementary Medicine Market Trends Together With Growth Forecast To 2026 – Owned

§ June 24th, 2020 § Filed under Quantum Medicine Comments Off on Alternative And Complementary Medicine Market Trends Together With Growth Forecast To 2026 – Owned

Alternative And Complementary Medicine Market report provide the COVID19 Outbreak Impact analysis of key factors influencing the growth of the market Size (Production, Value and Consumption). This Alternative And Complementary Medicine industry splits the breakdown (data status 2014-2020 and Six years forecast 2020-2026), by manufacturers, region, type and application. This study also analyses the Alternative And Complementary Medicine market Status, Market Share, Growth Rate, Future Trends, Market Drivers, Opportunities and Challenges, Risks and Entry Barriers, Sales Channels, Distributors and Porters Five Forces Analysis.

Alternative And Complementary Medicine Market competitive landscapes provides details by topmost manufactures like (Pacific Nutritional, Herb Pharm., Herbal Hills, Helio USA, Deepure Plus, Nordic Naturals, Pure encapsulations, Iyengar Yoga Institute, John Schumachers Unity Woods Yoga Center, Yoga Tree, The Healing Company, Quantum Touch), including Capacity, Production, Price, Revenue, Cost, Gross, Gross Margin, Growth Rate, Import, Export, Market Share and Technological Developments

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures)of Alternative And Complementary Medicine[emailprotected]https://www.researchmoz.us/enquiry.php?type=S&repid=2057476

Alternative And Complementary Medicine Market Competition by Manufacturers (2020 2026): Alternative And Complementary Medicine Market Share of Top 3 and Top 5 Manufacturers, Alternative And Complementary Medicine Market by Capacity, Production and Share by Manufacturers, Revenue and Share by Manufacturers, Average Price by Manufacturers By Market, Manufacturers Manufacturing Base Distribution, Sales Area, Product Type, Market Competitive Situation and Trends, Market Concentration Rate.

Scope of Alternative And Complementary Medicine Market:Alternative medicine involves the application of traditional methods of medication such as the use of herbs and other mind and body healing techniques that are mostly based on faith and belief. However, most of these techniques have no regulatory approval or clinical evidential backing. Many of the governments and regulatory bodies have put up efforts in finding clinical support for the incorporation of alternative treatments to help improve the market and treatment methods.

Europe is the source of most revenue generation in the market owing to the extensive use of botanicals in the regions. Botanicals such as dietary supplements witness considerable demand in countries like Germany and France.

On the other hand, Asia Pacific is set to grow at steady pace over the forecast years due to growth of medical tourism, expensive nature of conventional medicine and the fact that the region serves as the origin place for a number of key alternative medical therapies. The Middle East is transforming into a global hub of wellness medical infrastructure to become and is expected to be one of the rapidly growing regions in this market.

On the basis of product type, this report displays the shipments, revenue (Million USD), price, and market share and growth rate of each type.

Botanicals Acupuncture Mind Body and Yoga Magnetic Intervention

On the basis on the end users/applications,this report focuses on the status and outlook for major applications/end users, shipments, revenue (Million USD), price, and market share and growth rate foreach application.

Direct Contact E-training Distance Correspondence

Do You Have Any Query Or Specific Requirement? Ask to Our Industry[emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid=2057476

Alternative And Complementary Medicine Market: Regional analysis includes:

The Study Objectives Of This Alternative And Complementary Medicine Market Report Are:

Contact:

ResearchMoz Mr. Rohit Bhisey, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email:[emailprotected]

Browse More Reports Visit @https://www.mytradeinsight.blogspot.com/

Excerpt from:

Alternative And Complementary Medicine Market Trends Together With Growth Forecast To 2026 - Owned

Read the Rest...

Rare Disease Diagnostics: Assessment of Technologies and Global Markets with Profiles of 95+ Industry Players – ResearchAndMarkets.com – Business Wire

§ June 24th, 2020 § Filed under Quantum Medicine Comments Off on Rare Disease Diagnostics: Assessment of Technologies and Global Markets with Profiles of 95+ Industry Players – ResearchAndMarkets.com – Business Wire

DUBLIN--(BUSINESS WIRE)--The "Rare Disease Diagnostics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

The global rare disease diagnostics market should reach $26.7 billion by 2024 from $17 billion in 2019, rising at a CAGR of 9.5% over the forecast period.

The scope of the report includes rare disease diagnostic technologies, applications, industries, initiatives, patents and companies. The market for rare disease diagnostic products and services is given for 2018 and 2019, and then forecast through 2024.

This report reviews the main diagnostic technologies and explains why genetic variation is important in clinical testing and disease. It then discusses significant large-scale research initiatives that impact rare disease diagnostic applications. Of particular interest is a discussion of global population-scale sequencing projects and their likely impact in linking genetic variation to rare disease diagnostics. The main market driving forces for rare disease diagnostic products and services are listed and discussed.

The report categorizes and quantifies the rare disease diagnostics market by the disease category, technology platform, test purpose, analysis target and geography segments.

More than 95 companies in the rare disease diagnostic industry are profiled in this report.

The research also provides a summary of more than 50 of the main industry acquisitions and strategic alliances that took place from April 2018 through April 2020, including key alliance trends.

The report includes:

Market Insights

Rare diseases comprise a growing public health priority, as they affect upward of 300 million people globally and they are difficult to diagnose and treat.

There is a pressing need for better ways to detect and diagnose rare diseases, as well as to provide companion diagnostics for therapy guidance, clinical trials enrollment and therapy monitoring applications.

Better diagnostic tests for rare diseases can make significant differences in the lives of those affected by these conditions. Many rare diseases go undiagnosed for long periods of time because patients, families and physicians may have limited awareness of certain diseases, and the symptoms may not be informative to healthcare workers who may not have encountered such diseases before.

Extended time to diagnosis of a rare disease, along with so-called diagnostic odysseys, can lead to negative outcomes, including misdiagnosis or disease progression. Rapid, accurate diagnostics can significantly shorten these diagnostic odysseys.

In addition to early detection and diagnostic potential, rare disease therapeutics will be important in orphan drug development and use. Orphan drugs address rare disease patient populations, and they are expected to have a high growth rate through 2024. By 2024, orphan drugs may make up as much as one-fifth of global prescription sales. Rare disease diagnostics can be used to help physicians make proper decisions regarding which therapies to use and ways to monitor the efficacy of those therapies during treatment courses. Rare disease diagnostics can also be used to help select patients for orphan drug clinical trials.

More than 70% of rare diseases are inherited conditions, and they thus have genetic components, so this industry relies heavily on genetic analysis methods, including polymerase chain reaction (PCR), next-generation sequencing (NGS) and Sanger sequencing.

Key Topics Covered

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Overview

Chapter 4 Technology Background

Chapter 5 Rare Disease Diagnostics Initiatives

Chapter 6 Rare Disease Diagnostic Industries

Chapter 7 Rare Disease Diagnostics Strategic Alliances and Acquisitions

Chapter 8 Rare Disease Diagnostics Markets

Chapter 9 Rare Disease Diagnostics Patents and Intellectual Property

Chapter 10 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/q3uanz

The rest is here:

Rare Disease Diagnostics: Assessment of Technologies and Global Markets with Profiles of 95+ Industry Players - ResearchAndMarkets.com - Business Wire

Read the Rest...

It is false that the COVID-19 vaccine candidates are going to introduce a microchip – Explica

§ June 24th, 2020 § Filed under Quantum Medicine Comments Off on It is false that the COVID-19 vaccine candidates are going to introduce a microchip – Explica

A video of an alleged conversation by an instant messaging service circulates on the network in a group of friends in which one of them says that he works in a laboratory that is investigating the solution to COVID-19 and that they force them to design the vaccine but so that it is possible to introduce a capsule with it . This person ends up explaining that he fears that this is to implant a chip and control ourselves. However, this is not possible today. Its false.

This hoax joins many others that have spread in recent weeks about a possible introduction of microchips through the new COVID-19 vaccine candidates and who, in fact, They originate from an answer to a Reddit question by Microsoft creator tycoon Bill Gates, which was misinterpreted.

Gates in no case exposed on that network, nor later, as he explained in an article on his blog Gates Notes, that microchips can be inserted into vaccines, but eventually it is very likely that until there is a solution we will have some digital certificates to show who recently recovered or was tested and even when we have a vaccine to know who received it .

This clarification joins another that the philanthropist gave on June 3 at the virtual press conference prior to the GAVI donors conference, a global association dedicated to improving access to vaccination. In it Gates said that has never had anything to do with a microchip and that repeating it so many times almost seems to give it credibility, but that its foundation is simply dedicated to investing money to buy vaccines. However, the plots in the networks did not stop. One of the most famous, that of the president of the San Antonio de Murcia Catholic University, Jos Luis Mendoza, during the celebration of San Antonio de Padua on June 13. However, injection of chips into vaccines is currently not possible.

The Bill and Melinda Gates Foundation, in addition to investing money in purchasing and distributing vaccines, is also dedicated to researching some of the newest alternatives to solve COVID-19 and many other diseases. The latest innovations, the focus of RNA and DNA vaccines, as a result of which the hoax was also generated that human DNA is modified with them and that in Newtral.es we have already verified, or the therapeutic treatment research that can mitigate the effects of SARS-CoV-2 as using the blood (plasma) of people recoveringSince in principle these can have antibodies to protect people.

But this foundation also subsidizes private research projects with funds. One of them, the one published in December 2019 in the journal Science Translational Medicine dedicated to developing vaccines that would leave a kind of invisible tattoo under the skin (really some infrared light sensitive microparticles called quantum dots) and as a result of which it could be known with a modified smartphone whether or not that person has been vaccinated of something in particular.

In other words, the same as the digital QR or printed certificate that many countries are already distributing among their citizens, but under the skin. Even if remember that it is not entirely useful Because, as the World Health Organization (WHO) warns, there is no evidence that people who have recovered from COVID-19 and have antibodies are protected from a second infection.

This project has also been used to continue the hoax that Gates wants to introduce microchips into vaccines, but as you can see It has nothing to do with it. A microchip is not a microparticle. In addition, at the moment it has only been tested on mice and in any case that tattoo only remains for five years under the skin.

As explained by one of its authors, Kevin McHugh, assistant professor of bioengineering at Rice University in Houston, Texas, in statements to the Public Affairs Office of said university, the research intends to last at least two years and is aimed at the 1.5 million preventable deaths resulting from lack of vaccines, mainly in developing countries.

He also highlights that the project has two very positive sides, first that unnecessary vaccines are not administered, which has a cost, and second, but even greater, that does not leave people without immunity and at risk of contracting an infectious disease.

Regarding data protection, McHugh explained that people may choose not to participate as well as Does not say anything else about the person, only if you are vaccinated or not.

Sources

31 Questions and Answers About COVID-19, Bill Gates, Gates Notes, March 18, 2020 Bill Gates answers the conspiracy theories: I have nothing to do with a microchip. It is very stupid to have to deny this , Patricia Peir, El Pas, June 4, 2020 Bill Gates responds to conspiracy theories against him , Forbes, June 13, 2020Research article: Infrared quantum dots nearby biocompatibles that are delivered to the skin via microneedle patches record vaccination, Science Translational Medicine, December 18, 2019 Quantum Dot Tattoos Have Vaccination Record, Mike Williams, Rice University News, December 18, 2019 Storing Medical Information Beneath the Surface of the Skin, Anne Trafton, Massachusetts Institute of Technology News, December 18, 2019 No, the current coronavirus was no longer known at the 2012 Olympics and possible vaccines do not include a microchip of control, Verifies RTVE, June 17, 2016 Immunity passports in the context of COVID-19, World Health Organization, April 24, 2020

Originally posted here:

It is false that the COVID-19 vaccine candidates are going to introduce a microchip - Explica

Read the Rest...

dr-simon-whitesman-on-why-mindfulness-is-medicine – Longevity LIVE

§ June 17th, 2020 § Filed under Quantum Medicine Comments Off on dr-simon-whitesman-on-why-mindfulness-is-medicine – Longevity LIVE

Gisele Wertheim Aymes speaks to Dr. Simon Whitesman (MBChB) about why mindfulness is medicine. Dr. Whitesman is a practitioner of medical psychotherapy at Christiaan Barnard Memorial Hospital in Cape Town and chairman of the Institute of Mindfulness.

A: I always wanted to be a doctor. However, when I became one, the experience was nothing that I had imagined. There was a strong missing element. Then a colleague suggested I start meditating. I had heard of TM, so I went and did TM training. This helped me become very disciplined, and it made a relatively quick and deep impact on my physical well-being. I had suffered from tension headaches and now found relief. And it was this that started my scientific interest in meditation.

When I read Quantum Healing by Deepak Chopra, I experienced an epiphany. It was like walking into a room I had been in and recognizing everything.

It resonated with me. This idea that raising consciousness is the basis for all healing like a key fitting into a lock.

And from there I began an exploration of this insight. I have walked many paths as a psychotherapist. From mind-body connection and Buddhist contemplative therapies to more contemporary approaches to mindfulness. This is where I have really found more meaning now in a more contemporary approach to mindfulness.

A: I discovered it was about my own healing a parallel process while wanting to find expression as a clinician and a doctor. And then recognizing a symmetry on the inside that was compelling for me, in terms of my own path and personal growth.

Then, through Jon Kabat-Zinns work, I was exposed to mindfulness, which is not the same as TM.

Jon Kabat-Zinn is an American professor emeritus of medicine, and creator of the Stress Reduction Clinic and the Center for Mindfulness in Medicine, Health Care and Society at the University of Massachusetts Medical School, in the US. Kabat-Zinn was a student of Zen Buddhist teachers such as Philip Kapleau, Thich Nhat Hanh and Seung Sahn, and a founding member of the Cambridge Zen Center. His practice of yoga and studies with Buddhist teachers led him to integrate their teachings with scientific findings. He teaches mindfulness, which he says can help people cope with stress, anxiety, pain, and illness. The stress-reduction program created by Kabat-Zinn, mindfulness-based stress reduction (MBSR), is offered by medical centers, hospitals, and health-maintenance organizations.

A: The original roots of mindfulness are part of a set of teachings from Buddha 2 500 years ago. Buddha was a human who woke up to who he was and developed a way of teaching others to help them wake up. Central to this path was mindfulness. There were obviously many other aspects, but mindfulness was central.

Kabat-Zinn understood that there are so many people who could benefit from mindfulness, but who were not necessarily interested in Buddhist teachings. He developed mindfulness around keeping the essential qualities of Buddhism, but without the beliefs. You could say it is Buddhism without the belief. Its a contemporary re-contextualization of ancient wisdom and tradition. This meant that if you were a Catholic priest, you could benefit from mindfulness; it didnt conflict with your own set of beliefs. This was a subtle, but very important shift.

A: Mindfulness enables you to be more compassionate, more present, less reactive. Its meditation made more accessible.

Kabat-Zinn first offered it in a contemporary tertiary teaching hospital in Worcester, Massachusetts. He saw it could be a benefit for so many those suffering from chronic pain syndrome, the people who fall through the cracks. He told colleagues to send them to him. Kabat-Zinn taught these patients how to turn inward, to find a new way of being in pain. From there, his work expanded into other chronic disorders.

Medicine doesnt want to go there. I saw that, but for me, there is a desire to bring it back to my life. For me, it is not so much about mindfulness, but more heartfulness.

A: I went to the US and started training in that approach. While I had learned the TM technique, Jon Kabat-Zinn helped to orientate me to what meditation truly is.

What are you going to do when you finish meditation? When you finish meditating, can you make the next moment valuable, engaged, connected, awake, with a quality of curiosity, interested in your own experience? Its valuable to meditate, but the application is deeper than sitting and closing your eyes. Dedicate time to understanding your own mind. Its a willingness to explore and be interested in your own experience.

You dedicate time to silence, to understand your own mind better. Then I also need to get up and go to the world, be present in the world. Its always available to us. Awareness isnt going anywhere. Awareness is now, attending to each and every moment of our lives. Then life becomes meditation.

If you do take time to be with yourself, understand your relationship between body and mind, then life becomes a meditation. Its a radical shift in understanding, broadly and universally applicable. . Mindfulness isnt about thought; its prior to thought. Train yourself to be aware of the thought prior to its occurring.

A: Yes, agreed. We get lost in thinking. We lose a wider presence with our body. Most of us are lost in thinking the revered space between our left and right ear. And we lose our consciousness of Earth and others. You have to start with mindfulness of the body, then mindfulness of thoughts. And it becomes a trainable skill, an actual physiological skill transforming our own awareness. Not randomly, but in service of the greater good, to reduce our own suffering, then the suffering of others. In order to experience a more meaningful existence and live life, we have to train our minds.

When you train for the Two Oceans, you train your body extensively. You cant run a marathon if you havent trained physically. People think the mind is easier. Its not. Youre asking people to open up and be uncomfortable. Gym is not comfortable; gym can be hard. Its the same as training for consciousness. It isnt easy, but it is simple.

Mindfulness is about focusing on the present, not worrying about yesterday or tomorrow.

A cartoon shows two Buddhist monks sitting side by side. Theyre deep in meditation when the younger one opens an eye and gives the older, wiser one a questioning look.

Nothing happens next. This is it, the older one responds.

I treat mindfulness daily in my practice, and I teach an eight-week program on mindfulness. We are training professionals in mindfulness at the Faculty of Medicine at Stellenbosch University. Its much broader than doctors. We train the trainers through the Faculty of Medicine and Health Sciences. This is the only university in South Africa that offers this course. I also contribute towards IMEISA, a non-profit around mindfulness, to create more awareness and debunk myths around mindfulness.

Everyone can benefit from mindfulness. However, the only way you will know the benefit is if you practice. It will be in your own experience. However, for me, I saw my own changes: reduced reactivity and stronger connection with myself and others, as well as everything around me. Its the human condition to be lost in thought. We cant connect if were not present. Something happens when we dont make our mind the enemy. Be more engaged in the moment. Its not an idea; its a truth.

This is how mindfulness can heal trauma. Read more.

Apart from his role as a practitioner of medical psychotherapy at Christiaan Barnard Memorial Hospital in Cape Town, Dr Simon Whitesman is the co-ordinator of the post-graduate certificate training in Mindfulness-Based Interventions at Stellenbosch Universitys Faculty of Medicine and Health Sciences. Hes also director and chairperson of the Institute for Mindfulness South Africa (IMISA), and co-director of the first Mindfulness-Based Stress Reduction (MBSR) program in South Africa. He received certification as a teacher in MBSR from the University of Massachusetts Center for Mindfulness, and in psychoanalytic psychotherapy from the South African Institute for Psychotherapy.

See more here:

dr-simon-whitesman-on-why-mindfulness-is-medicine - Longevity LIVE

Read the Rest...

COVID-19, modern medicine and the hidden world of data – Investment Magazine

§ June 17th, 2020 § Filed under Quantum Medicine Comments Off on COVID-19, modern medicine and the hidden world of data – Investment Magazine

The threat of COVID-19 still remains.

Since the first confirmed case of COVID-19 was identified in Australia on 25 January this year, an eerie pall has descended across the country. Shortly thereafter domestic borders were closed to all non-residents, non-essential services were closed down, and we were all introduced to the term social distancing. The action was swift, leading to significant volatility in financial markets and the introduction of a raft of government economic support measures.

However, what most people are unaware of is the quantum change that has taken place with how society approaches a pandemic.

Dr John Fraser, professor at Prince Charles Hospitals faculty of medicine at The University of Queensland, explained to Investment Magazine the dilemma posed to medical professionals in offering treatment to a new pandemic. In recognising the inherent information asymmetry when studying the virus locally, Fraser helped devise the Critical Care Consortium, a collaboration between 350 hospitals in 49 countries to collate, analyse and understand COVID-19 patient data.

Professor Frasers was the highest-rated speaker at the Fiduciary Investors Symposium, watch now and find out why.

Alongside mining the raw data, the consortium has been able to reach agreements with Amazon and IBM to create Bruce, a real-time med-tech device that aggregates patient information to the cloud. This data can then be catalogued and applied to cases that are new to the attending medics but not without precedent in other hospitals.

This confluence of creative thinking, technology and cooperation could be invaluable in mitigating the impact of coronavirus as it mutates and evolves. Just this week, Beijing has entered a second phase of lockdowns, daily new cases continue to rise globally, and the state of Victoria has seen a spike in cases.

Given that a vaccine isnt currently available, and may never be, our hopes are in the hands of the heroes working behind the scenes utilising live empirical data and treatments to offer a return to normality.

To continue the conversation on reformed fiduciary thinking towards health, public policy, and investments, join us at the Top1000funds Fiduciary Investors Symposium Digital 2020 on June 23 and 24. View the full program and register at http://www.fiduciaryinvestors.com

See the original post here:

COVID-19, modern medicine and the hidden world of data - Investment Magazine

Read the Rest...

How Coronavirus Pandemic Will Impact Alternative And Complementary Medicine Market: Comprehensive analysis of factors that drive market growth – 3rd…

§ June 15th, 2020 § Filed under Quantum Medicine Comments Off on How Coronavirus Pandemic Will Impact Alternative And Complementary Medicine Market: Comprehensive analysis of factors that drive market growth – 3rd…

The Alternative And Complementary Medicine Market research report enhanced worldwide Coronavirus COVID19 impact analysis on the market size (Value, Production and Consumption), splits the breakdown (Data Status 2014-2020 and 6 Year Forecast From 2020 to 2026), by region, manufacturers, type and End User/application. This Alternative And Complementary Medicine market report covers the worldwide top manufacturers like (Pacific Nutritional, Herb Pharm., Herbal Hills, Helio USA, Deepure Plus, Nordic Naturals, Pure encapsulations, Iyengar Yoga Institute, John Schumachers Unity Woods Yoga Center, Yoga Tree, The Healing Company, Quantum Touch) which including information such as: Capacity, Production, Price, Sales, Revenue, Shipment, Gross, Gross Profit, Import, Export, Interview Record, Business Distribution etc., these data help the consumer know about the Alternative And Complementary Medicine market competitors better. It covers Regional Segment Analysis, Type, Application, Major Manufactures, Alternative And Complementary Medicine Industry Chain Analysis, Competitive Insights and Macroeconomic Analysis.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures)of Alternative And Complementary Medicine[emailprotected]https://www.researchmoz.us/enquiry.php?type=S&repid=2057476

Alternative And Complementary Medicine Market report offers comprehensive assessment of 1) Executive Summary, 2) Market Overview, 3) Key Market Trends, 4) Key Success Factors, 5) Alternative And Complementary Medicine Market Demand/Consumption (Value or Size in US$ Mn) Analysis, 6) Alternative And Complementary Medicine Market Background, 7) Alternative And Complementary Medicine industry Analysis & Forecast 20202026 by Type, Application and Region, 8) Alternative And Complementary Medicine Market Structure Analysis, 9) Competition Landscape, 10) Company Share and Company Profiles, 11) Assumptions and Acronyms and, 12) Research Methodology etc.

Scope of Alternative And Complementary Medicine Market:Alternative medicine involves the application of traditional methods of medication such as the use of herbs and other mind and body healing techniques that are mostly based on faith and belief. However, most of these techniques have no regulatory approval or clinical evidential backing. Many of the governments and regulatory bodies have put up efforts in finding clinical support for the incorporation of alternative treatments to help improve the market and treatment methods.

Europe is the source of most revenue generation in the market owing to the extensive use of botanicals in the regions. Botanicals such as dietary supplements witness considerable demand in countries like Germany and France.

On the other hand, Asia Pacific is set to grow at steady pace over the forecast years due to growth of medical tourism, expensive nature of conventional medicine and the fact that the region serves as the origin place for a number of key alternative medical therapies. The Middle East is transforming into a global hub of wellness medical infrastructure to become and is expected to be one of the rapidly growing regions in this market.

On the basis on the end users/applications,this report focuses on the status and outlook for major applications/end users, shipments, revenue (Million USD), price, and market share and growth rate foreach application.

Direct Contact E-training Distance Correspondence

On the basis of product type, this report displays the shipments, revenue (Million USD), price, and market share and growth rate of each type.

Botanicals Acupuncture Mind Body and Yoga Magnetic Intervention

Do You Have Any Query Or Specific Requirement? Ask to Our Industry[emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid=2057476

Geographically, the report includes the research on production, consumption, revenue, Alternative And Complementary Medicine market share and growth rate, and forecast (2020-2026) of the following regions:

Important Alternative And Complementary Medicine Market Data Available In This Report:

Strategic Recommendations, Forecast Growth Areasof the Alternative And Complementary Medicine Market.

Challengesfor the New Entrants,TrendsMarketDrivers.

Emerging Opportunities,Competitive Landscape,Revenue Shareof Main Manufacturers.

This Report Discusses the Alternative And Complementary Medicine MarketSummary; MarketScopeGives A BriefOutlineof theAlternative And Complementary Medicine Market.

Key Performing Regions (APAC, EMEA, Americas) Along With Their Major Countries Are Detailed In This Report.

Company Profiles, Product Analysis,Marketing Strategies, Emerging Market Segments and Comprehensive Analysis of Alternative And Complementary Medicine Market.

Alternative And Complementary Medicine Market ShareYear-Over-Year Growthof Key Players in Promising Regions.

What is the (North America, South America, Europe, Africa, Middle East, Asia, China, Japan)production, production value, consumption, consumption value, import and exportof Alternative And Complementary Medicine market?

To Get Discount of Alternative And Complementary Medicine Market:https://www.researchmoz.us/enquiry.php?type=D&repid=2057476

Contact:

ResearchMoz Mr. Rohit Bhisey, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email:[emailprotected]

Browse More Reports Visit @https://www.mytradeinsight.blogspot.com/

See more here:

How Coronavirus Pandemic Will Impact Alternative And Complementary Medicine Market: Comprehensive analysis of factors that drive market growth - 3rd...

Read the Rest...

« Older Entries



Page 11234